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Abstract 
The cystic fibrosis transmembrane conductance regulator (CFTR) is a 
chloride channel member of the ATP-binding cassette (ABC) superfamily of 
membrane proteins. CFTR has two homologous halves, each consisting of six 
transmembrane spanning domains (TM) followed by a nucleotide binding fold, 
connected by a regulatory (R) domain. This thesis addresses the question of 
which domains are responsible for Cl- selectivity, i.e., which domains line the 
channel pore. 
To address this question, novel blockers of CFTR were characterized. 
CFTR was heterologously expressed in Xenopus oocytes to study the 
mechanism of block by two closely related arylaminobenzoates, 
diphenylamine-2-carboxylic acid (DPC) and flufenamic acid (FFA). Block by 
both is voltage-dependent, with a binding site "" 40% through the electric field 
of the membrane. DPC and FFA can both reach their binding site from either 
side of the membrane to produce a flickering block of CFTR single channels. 
In addition, DPC block is influenced by Cl- concentration, and DPC blocks with 
a bimolecular forward binding rate and a unimolecular dissociation rate. 
Therefore, DPC and FFA are open-channel blockers of CFTR, and a residue of 
CFTR whose mutation affects their binding must line the pore. 
Screening of site-directed mutants for altered DPC binding affinity 
reveals that TM-6 and TM-12 line the pore. Mutation of residue S341 in TM-6 
abolishes most DPC block, greatly reduces single-channel conductance, and 
iv 
alters the direction of current rectification. Additional residues are found in 
TM-6 (K335) and TM-12 (T1134) whose mutations weaken or strengthen DPC 
block; other mutations move the DPC binding site from TM-6 to TM-12. The 
strengthened block and lower conductance due to mutation Tl134F is 
quantitated at the single-channel level. The geometry of DPC and of the 
residues mutated suggest a-helical structures for TM-6 and TM-12. Evidence is 
presented that the effects of the mutations are due to direct side-chain 
interaction, and not to allosteric effects propagated through the protein. 
Mutations are also made in TM-11, including mutation S1118F, which gives 
voltage-dependent current relaxations. The results may guide future studies on 
permeation through ABC transporters and through other Cl- channels. 
v 
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Introduction 
Background 
In trod uction-1 
Cystic fibrosis is the most common lethal inherited disease among 
Caucasian populations. The carrier frequency is approximately one out of 
twenty. Clinical manifestations of CF include salty skin, pancreatic 
insufficiency, infertility, and the accumulation of thick mucus in respiratory 
tracts (Boat et al., 1989). Mortality is usually due to bacterial infection of the 
respiratory mucus. The various symptoms of cystic fibrosis were first 
recognized as a unified syndrome in the 1930s, although European folklore 
from as early as the seventeenth century associates salty skin with premature 
death (Taussig, 1984). 
Work in the early 1980s linked cystic fibrosis to defects in epithelial 
chloride permeability. First, in vivo experiments found an abnormally 
hyperpolarized transepithelial potential difference of nasal respiratory tissue in 
patients with cystic fibrosis as compared to controls (Knowles et al., 1981). 
Soon afterward, this abnormal hyperpolarization was also observed in sweat 
glands and was traced to a defect in CI-, rather than sodium, permeability 
(Quinton, 1983; Quinton and Bijman, 1983). Single-channel physiology 
identified several Cl- channels prominent in secretory epithelia. Most work 
focused on an outwardly-rectifying Cl- channel (ORCC) abundant in both 
normal and cystic fibrosis epithelia. The activation of this channel by the 
protein kinase A pathway was found defective in cystic fibrosis epithelia 
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(Welsh and Liedtke, 1986; Welsh, 1986; Frizzell et al., 1986). Most concluded 
that the gene defective in cystic fibrosis was either this Cl- channel or a 
controller of Cl- channels in epithelial cells. 
In 1989, the gene defective in cystic fibrosis was cloned (Riordan et al., 
1989; Rommens et al., 1989). Surprisingly, the gene product was not 
homologous to known ion channels, but was identified as a member of the 
ATP-binding cassette (ABC) superfamily. The gene product was named the 
cystic fibrosis transmembrane conductance regulator, or CFTR. From the 
primary sequence, CFTR was predicted to have two homologous halves, each 
consisting of six transmembrane domains followed by a consensus A TP-
binding motif. The two halves are connected by a highly charged regulatory 
("R") domain, a domain also containing multiple consensus protein kinase A 
and C phosphorylation sites (see chapter 3, figure 1). The CFTR expression 
pattern agreed with expectations: it was localized to the apical membrane of 
secretory epithelial cells (Denning et al., 1992; Crawford et al., 1991). CFTR has 
also been found in pancreatic ducts and intestinal tract, and in reproductive 
tissue (Trezise et al., 1992). CFTR also exists in cardiac tissue, likely as an 
alternatively-spliced isoform (Horowitz et al., 1993; Nagel et al., 1992). 
Approximately 70% of cystic fibrosis mutations are due to the deletion 
of a single phenylalanine residue in the first nucleotide binding fold (Riordan, 
1993); it was later found that the CFTMF508 protein fails to reach the apical 
membrane in mammalian cells (Cheng et al., 1990). Heterologous expression of 
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wildtype CFTR, but not CFT~508, in cystic fibrosis cells corrects the defect in 
c1· permeability (Rich et al., 1990). The question remained, however, whether 
CFTR was a Cl- channel or a regulator of other c1· channels. 
Since the cloning of CFTR, many experiments have shown unequivocally 
that the CFTR gene product is itself a c1· channel. Expression of CFTR in a 
variety of cell types results in a channel different from that initially expected, a 
low conductance (::::: 10 picosiemens) Cl" channel with a linear current-voltage 
relation (Tabcharani et al., 1991; Kartner et al., 1991). A channel with the same 
properties is found in untransfected, cultured epithelial cell lines (Tabcharani et 
al., 1990). Point mutations of charged residues in CFTR give slight changes in 
anion selectivity (Anderson et al., 1991). Most significantly, when purified and 
reconstituted in lipid bilayers, CFTR forms a c1· channel with conductance, 
kinetics, and regulation identical to those described in expression studies (Bear 
et al., 1992). For a comprehensive review of CFTR, see Riordan, 1993. 
Although CFTR forms a c1· channel, its topology, homologous not to 
other channels but to the ABC superfamily, presents a major paradox. Many 
members of the ABC superfamily proteins form ATP-dependent transporters 
that pump diverse organic substrates. One such member is MDR, the 
multidrug resistance P-glycoprotein, which hydrolyzes ATP to pump 
hydrophobic drugs out of a variety of tumor cells. Another ABC superfamily 
member is the dimeric peptide transporter, with subunits TAP-1 and TAP-2, 
which pumps cytoplasmically produced antigen fragments into the 
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endoplasmic reticulum for association with the gene products of the major 
histocompatability locus. Other ABC transporters include the bacterial 
histidine permease, the yeast a mating factor transporter, and the genes whose 
mutations cause Zellweger syndrome or adrenoleukodystrophy. For a review 
of the ABC superfamily, see Higgins, 1992. 
Goals 
The goal of this research is to localize the permeation pathway of CFTR. 
Put another way, the goal is to determine what residues line the pore of CFTR, 
and thus how CFTR can function as a c1· channel. Defining the pore-lining 
domains responsible for Cl" selectivity would (1) have bearing on the 
mechanisms for substrate specificity of other ABC transporters, with 
corresponding medical implications for cancer treatment, immunological 
specificity, and diabetes, among other diseases; and (2) guide future structure-
function and biophysical work on other cloned c1· channels, a field that has 
lagged far behind cation channels. 
The strategy to localize the permeation pathway of CFTR involved the 
discovery and characterization of blockers of CFTR, itself a novel conclusion. 
In brief, the strategy involved: (1) developing an open-channel blocker of 
CFTR; and (2) using site-directed mutagenesis to find residues that, when 
mutated, alter or abolish the open-channel block. Such residues must line the 
pore. 
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Chapter one is a review of structure-function work done to date on ion 
channels, and it places the following work on CFTR into context. Chapter two 
is devoted to the expression of CFTR channels in Xenopus oocytes and the 
characterization of two closely related blockers of CFTR, diphenylamine-2-
carboxylic acid (DPC) and flufenamic acid (FFA). Chapter three presents 
further proof of the mechanism of DPC block, describes the effects of site-
directed mutagenesis of CFTR on DPC block, and presents the resulting 
concept of the channel pore. Chapter four describes further mutations. 
Data Summary and Conclusions 
(1) DPC is an open-channel blocker of CFTR. DPC block of CFTR is 
voltage-dependent, and at the single-channel level, DPC produces brief, flickery 
closures with voltage-dependence and kinetics consistent with whole-cell 
measurements. In addition, the DPC block is changed by reduced Cl-
concentration, evidence that DPC and cl- interact within the pore. Experiments 
done on a mutant CFTR with more resolvable kinetics show that the rate of 
DPC block increases linearly with DPC concentration, while the rate constant 
for unblocking is concentration-independent. This is in agreement with 
classical kinetic models for open-channel blockers. Moreover, mutations within 
putative transmembrane domains are found that w eaken or strengthen DPC 
block, further evidence that DPC binds within the pore. (2) Flufenamic acid is 
also an open-channel blocker of CFTR. FFA is identical to DPC, but with the 
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addition of a single trifluoromethyl group. Its block is flickery, with the same 
voltage-dependence as that of DPC. Its on-rate is similar to that of DPC, yet its 
off-rate is lower, resulting in a residence time on the channel double that of 
DPC. 
(3) Residues in transmembrane domains (TM) six and twelve line the pore. 
Residue serine 341, at a position in TM-6 corresponding to the electrical 
position of the DPC binding site, is vital for DPC binding and cl- permeation. 
Mutation of 5341 to alanine eliminates most DPC block, reduces single-channel 
conductance almost tenfold, and alters rectification. Once the binding site in 
TM-6 is eliminated, however, it can be reconstructed in TM-12, showing that 
TM-12 also lines the pore. Another mutation in TM-12 (T1134F) strengthens 
the block, and another residue in TM-6 (K335) is found that affects block and 
rectification. The T1134F mutation also lowers single-channel conductance by 
:::::: 25%; single-channel measurements of block correlate quantitatively with 
whole-cell measurements. Other mutations have no effects; these and other 
arguments discount the possibility that the mutations are having allosteric 
effects. Analysis of the geometry of the DPC molecule and the residues 
mutated shows that (4) Transmembrane domains six and twelve are a-helical, at 
least in the span around the DPC binding site. In this respect, CFTR is like the 
members of the ligand-gated channel superfamily, and unlike K+ channels. 
The results described here are in accordance with work done on other 
ABC transporters, and with previous studies on CFTR and on other ion 
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channels. As discussed more fully in chapter 3, these results represent a step 
towards bridging the gap between transporters and channels. 
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An Overview of the Relationship Between 
Structure and Function in Ion Channels 
Stefan McDonough and Henry A. Lester 
Division of Biology 
California Institute of Technology 
Pasadena, California 91125 
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This review briefly introduces the known classes of ion channels, 
describes conceptual insights gained from structure-function work, and 
discusses the limitations of the techniques used. Finally, unresolved issues and 
promising future directions are highlighted. 
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"Structure- function" studies are ultimately aimed at explaining the 
various functional properties of ion channels, such as permeation and gating, at 
the level of 3-dimensional structures and motions. At present, structure-
function studies have the interim goal of evaluating the role played by 
individual residues in the protein sequence. Such studies are most often 
accomplished by in vitro mutagenesis of one or more codons in a cloned 
complementary DNA. The experimenter then compares the electrophysiology 
or pharmacology of the mutant protein with wild-type protein. At the present 
state of the field, determination of the function of a domain in the primary 
protein sequence rarely gives unambiguous information about the actual 
"structure" of the domain. Mutagenesis and expression has provided actual 
structural data in only a handful of cases, including the conclusion that the 
pore-lining transmembrane domains of the acetylcholine receptor are a-helical 
(Lester, 1992), and that the transmembrane domains of the pore region of the 
Shaker potassium channel are ~-strands (Yellen et al., 1991). Mutagenesis and 
expression does, however, localize functions of a protein to particular domains, 
or, in some cases, to particular residues. 
Mutagenesis and expression are preceded by careful inspection of the 
predicted primary amino acid sequence. In many cases, such study reveals 
consensus functional motifs. Consecutive stretches of hydrophobic residues 
may signify transmembrane domains, while presence of anN-terminal signal 
sequence indicates an extracellular N-terminal. Other well-known protein 
motifs include phosphorylation target sequences, ATP binding domains 




Such methods applied to the sequences of cloned channels reveal a 
number of distinct families. For a review of the evolution of channel families, 
see Jan and Jan, 1992b. The well-known voltage-gated channel family 
encompasses voltage-gated sodium, potassium, and calcium channels, reviewed 
extensively in later chapters. The basic subunit for this family is a polypeptide 
with cytoplasmic N- and C- termini and six membrane spanning domains, 
termed S1-S6. For Na+ and Ca2+ channels, four subunits are linked in an 
internal repeat to form a presumed monomeric channel; forK+ channels, four 
subunits coassemble to form a tetrameric channel (MacKinnon, 1991). 
One common feature of voltage-gated channels is the pattern (R/K-X-X)n 
in S4, where X is a residue with a hydrophobic side chain, and n is 6-7. The S4 
region is thought to play a major role in sensing changes in the membrane 
potential, as discussed below. A second common feature is a domain (termed 
SS1-SS2, S5-S6, HS, or, most commonly, the P region) between SS and S6 that 
forms at least part of the pore for voltage-gated channels (Hartman et al., 1991; 
Yool and Schwartz, 1991; MacKinnon and Miller, 1989; Heinemann et al., 1992). 
This family also includes a subfamily of Ca2+-activated K+ channels (Atkinson 
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et al., 1991; Adelman et al., 1992; Butler et al., 1993) and a plant K+ channel 
(Anderson et al., 1992). The recently cloned amiloride-sensitive epithelial Na+ 
channel is apparently unrelated (Lingueglia et al., 1993; Canessa et al., 1994). 
The voltage-gated Na+, K+, and Ca2+ channels control nerve impulse 
conduction and frequency, and they are common targets for anesthetics. Some 
Ca2+ channels, reviewed in later chapters, are the link between electrical and 
chemical signal transduction. As such, they have especially wide relevance to 
drug design in many systems. They are especially important in the immune 
response, in heartbeat regulation, in transmitter release, and in cardiac muscle 
contraction. A subclass of Ca2+ channels comprise the target for the Ca2+ 
blockers such as nifedipine. 
Closely related to the voltage-gated family are the cyclic nucleotide-
gated channels important in visual and olfactory signal transduction. The 
amino acid sequence from the cloning of the retinal rod channel (Kaupp et al., 
1989) and the CNG-channel of olfactory neurons (Dhallan et al., 1990) predicts 
a structure similar to that of the voltage-gated family, with six transmembrane 
domains, a charged S4 region, and a P region recently shown to line the pore 
(Goulding et al., 1993; Root and MacKinnon, 1993). The P-region of voltage-
gated channels has two adjacent residues that do not appear in the 
homologous position of CNG channels. When voltage-gated K+ channels are 
mutated to eliminate these two residues, K+ selectivity is abolished, and the 
channel is blocked by divalent cations; these are pore characteristics of K+ 
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channels (Heginbotham et al., 1992). These results demonstrate the close 
evolutionary relationship between CNG channels and voltage-gated channels. 
In CNG channels, a long cytoplasmic C-terminal region contains the cyclic 
nucleotide binding site. Hill coefficients for ligand binding suggest that the full 
channel is an oligomer, and the resemblance to K+ channels suggests a tetramer 
(Kaupp, 1991). Additional subunits of both the retinal and olfactory channels 
have recently been cloned; there is good evidence that the endogenous channel 
is actually a heteroligomer of both types of subunit (Chen et al., 1993; K. Zinn, 
personal communication; L. Buck, personal communication). 
A new family of cloned K+ channels, long-anticipated from physiology 
on animal cells, are the inward rectifiers. Sequence analysis of known clones 
predicts cytoplasmic N- and C- terminii, with two transmembrane domains 
(M1 and M2) separated by a P region homologous to that found for voltage-
gated K+ channels. The first inward rectifiers were cloned by expression, 
ROMK1 from rat kidney (Ho et al., 1993), and IRK-1 from mouse macrophage 
(Kubo et al., 1993). Intriguingly, chimeras between IRK-1 and ROMK1 suggest 
that it is not the P region, but the region C-terminal to M2 that governs Mg2+ 
block; both regions affect channel conductance (Taglialatela et al., 1994). This 
implies that the C-terminal region may in fact cross the membrane one or more 
times. The latest addition to the inward rectifier family is the atrial G-protein 
activated K+ channel, termed either KGA (Dascal et al., 1993) or GIRK-1 (Kubo 
et al., 1993). Some or all of the inward rectification intrinsic to this family is 
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due to block by cytoplasmic Mg2+ (Vandenberg, 1987; Matsuda et al., 1987; 
Stanfield et al., 1994; Taglialatela et al., 1994). Future structure-function work 
on these channels will elucidate the domains responsible for regulation and 
pharmacology. It remains to be seen whether KGA/ GIRK1 accounts for 
inwardly rectifying K+ conductances coupled to additional 7-helix receptors 
such as }1- and b- opioid, a2 adrenergic, somatostatin, serotonin 1A, 1B, and 
1D, adenosine, GABA8 , galanin, and dopamine receptors (North, 1989); they 
may be sites for future antipsychotic or analgesic drugs. 
Also important in synaptic transmission are the well-known ion channels 
of the ligand-gated superfamily. Members of this family encode a ligand-
binding domain for neurotransmitters and an ion channel for post-synaptic 
excitation or inhibition in the same protein. The prototype for the family, and 
the first cloned ion channel (Noda et al., 1983), is the nicotinic acetylcholine 
receptor, found in mammalian muscle and Torpedo electroplax. The receptor 
has pentameric subunit stoichiometry, with five subunits arranged around a 
central pore (Unwin, 1989; Unwin, 1993). Each subunit has a long extracellular 
N-terminal region containing the ligand-binding site, and four predicted 
transmembrane domains. Homologous nicotinic acetylcholine receptors are 
found in the peripheral and central nervous sytems. Other members of the 
superfamily that also form non-selective cation channels are the NMDA- and 
non-NMDA type glutamate receptors, the 5-HT3 serotonin receptor, and 
probably some A TP receptors. The GABAA and glycine receptors form c1· 
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channels. Mammalian GABA receptors are the target for the anxiolytic 
benzodiazepines. For review of this superfamily, see Hille, 1992, chapters six 
and nine. 
Chloride channels 
Cloned c1· channels are still few in number, and thus represent a new 
frontier of ion channel research. As such, they are worth considering in more 
detail. Even the few c1· channels cloned so far play exceptionally diverse roles 
in vivo--muscle contraction, epithelial secretion, and volume regulation, as well 
as inhibitory neuronal transmission. These and future channels may be targets 
of drugs regulating immune responses, electrolyte balance, and the central 
nervous system. Intriguingly, c1· channels overlap several families of channels. 
The longest known cloned Cl· channels are the GABAA (Schofield et al., 1987) 
and glycine (Grenningloh et al., 1987; Grenningloh et al., 1990) receptor 
channels. These are expressed predominantly in neuronal tissue. 
Another well-studied c1· channel is the cystic fibrosis transmembrane 
conductance regulator (CFTR), whose mutation causes cystic fibrosis (Riordan 
et al., 1989; Rommens et al., 1989). CFTR is a member of the ATP-binding 
cassette protein superfamily (for review see Higgins, 1992). Sequence analysis 
predicts two homologous domains, each consisting of six transmembrane 
domains and a nucleotide binding fold, linked by a regulatory (R) domain (for 
review see Riordan, 1993). CFTR is activated dually by protein kinase A 
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phosphorylation and hydrolysis of ATP (Anderson et al., 1991). Initial reports 
indicated that a close relative of CFTR, the multidrug resistance transporter, 
was also a Cl- channel (Valverde et al., 1992; Gill et al., 1992). This remains 
controversial (Ehring et al., 1994). 
More recently cloned c1· channels form a distinct family unrelated to 
other channels. The voltage-gated Cl- channel from Torpedo, termed ClC-0, was 
cloned in 1990 by functional expression Gentsch et al., 1990); hydropathy 
analysis predicts 12 (possibly 13) transmembrane domains. Based on homology 
to ClC-0, the skeletal muscle c1· channel ClC-1 was cloned (Steinmeyer et al., 
1991), followed by ClC-2 (Thiemann et al., 1992), ClC-K1 (Uchida et al., 1993) 
and ClC-3 (Kawasaki et al., 1994). More are doubtless on the way. All 
members of the family have 12 putative transmembrane domains, with a long 
intracellular cytoplasmic domain (termed D13) that includes a hydrophobic 
stretch. 
The members of the ClC family have intriguing functional properties 
and patterns of expression. ClC-0 forms a double-barreled Cl- channel when 
expressed in Xenopus oocytes (Bauer et al., 1991), consistent with the original 
description of the reconstituted Torpedo protein (Hanke and Miller, 1983). ClC-
1 is developmentally regulated and specifically expressed in skeletal muscle 
(Steinmeyer et al., 1991), while ClC-2 is expressed in pancreas, lung, and liver 
tissue, as well as in brain and muscle (Thiemann et al., 1992). Mutations in 
ClC-1 can cause recessive and dominant myotonia congenita (Koch et al., 1992). 
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Interestingly, analysis of these mutations suggests that like K+ channels, ClC-1 
is a homotetramer (Steinmeyer et al., 1994). Unlike other members of the 
family, ClC-2 is volume-regulated (Grunder et al., 1992). ClC-3 is expressed in 
rat brain, and its activity in oocytes is inhibited by activation of protein kinase 
C (Kawasaki et al., 1994), implying an important role in signal transduction. 
ClC-K1 expresses predominantly in kidney (Uchida et al., 1993); it may 
regulate urinary electrolyte concentration. ClC-0, 1, and 2 share"" 50% 
sequence identity among themselves, "" 40% identity with ClC-K1, and"" 25% 
identity with ClC-3. Further investigation of the novel gating, permeation, and 
modulation mechanisms of this family will make fertile ground for structure-
function work. 
Historically, the vast number of c1· conductances have taken a back seat 
to cationic conductances. With so many exciting new clones, an explosion in 
c1· channel molecular biology cannot be far off. A most eagerly awaited clone 
is the epithelial outward rectifier Cl- channel whose regulation is defective in 
cystic fibrosis (Gabriel et al., 1993; Egan et al., 1992) and which may be the 
main mechanism of c1· secretion in airway epithelia (Stutts et al., 1992). 
An emerging class of molecules related to ion channels, with great 
potential relevance to drug design, are the neurotransmitter transporters; for 
comprehensive review, see Lester et al., 1994. Energy for neurotransmitter 
transport is often obtained from cotransport of inorganic ions. Plasma 
membrane transporters serve to remove neurotransmitters from the synaptic 
I-ll 
cleft after their release; vesicular transporters concentrate neurotransmitters into 
presynaptic vesicles prior to release. These two subfamilies each have 12 
putative transmembrane domains, though they share no significant sequence 
homology. Cloned transporters include those for GABA (Guastella et al., 1990), 
norepinephrine (Pacholczyk et al., 1991), dopamine (Kilty et al., 1991; Shimada 
et al., 1991), serotonin (Hoffman et al., 1991), and glycine (Guastella et al., 
1992). The recently cloned glutamate transporters (Pines et al., 1992) form a 
separate subfamily with fewer transmembrane domains. Of clinical relevance, 
drug abuse and clinical depression have been linked to defects in 
neurotransmitter transport. Cocaine blocks dopamine, serotonin, and 
norepinephrine transporters (Ritz et al., 1987; Kuhar et al., 1991), and newer 
antidepressants such as fluoxetine specifically inhibit serotonin uptake (Fuller 
and Wong, 1990). Structure-function work will identify the activation, 
modulation, and blocking mechanisms for these transporters. 
Common functional domains 
Especially when combined with electrophysiology, mutagenesis is the 
most sensitive tool available for domain analysis. Domains within proteins 
involved in activation, inactivation, ion selectivity, ligand binding, and subunit 
assembly have all been localized. Of special relevance to drug discovery, as 
developed in the previous chapter, is the identification of ion channel blocker 
or toxin binding sites. Mapping of such sites serves as a tool for channel 
analysis, as developed below, and structure-function techniques may allow 
detailed reverse pharmacology on any cloned channel of medical interest. 
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In addition to detailed characterization of individual channels, structure-
function work has given new conceptual insights about ion channels in general. 
A large advance in thought is that separate domains of ion channels are indeed 
responsible for distinct functions in some cases, as originally postulated by 
Hodgkin and Huxley for activation and inactivation gating (Hodgkin and 
Huxley, 1952). For example, the fast inactivation gate of the Shaker K+ channel 
can be removed without perturbing single-channel conductance or activation 
(Hoshi et al., 1990). As another example, introduction of three residues from 
the M2 sequence of a GABA" receptor into the M2 pore-lining region of the 
homomeric a7 acetylcholine receptor results in a channel gated by 
acetylcholine, but selective for c1· (Galzi et al., 1992). Although some studies, 
particularly on activation gating, have given more complex results, 
physiologists routinely speak of separable selectivity domains or gating 
regions. 
Detailed structure-function studies on a wide array of channels give a 
picture of mechanisms common within families. The positively charged S4 
regions of voltage-gated channels are common to K+ channels and to each of 
the four linked domains of Na+ and Ca2+ channels. Replacement of the 
individual charged residues within 54 leads to reductions in gating charge for 
both K+ (Papazian et al., 1991; Logothetis et al., 1992) and Na+ (Stuhmer et al., 
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1989) channels, although the individual contributions of each of the charges are 
non-equivalent. Other mutations of hydrophobic residues within S4, but not 
within any other putative transmembrane domains, shift the voltage-
dependence of gating (Auld et al., 1990; Lopez et al., 1991). Even CNG 
channels retain a small voltage sensitivity, presumably due to a poorly 
conserved 54 region that comprises fewer R/K residues than found in the true 
voltage-gated channels. 
Inactivation gating is also common among the members of the voltage-
gated channel family. In Na+ channels, disruption of the positively charged 
linker between domains ill and IV removes fast inactivation (Stuhmer et al., 
1989). Similar charged cytoplasmic domains have been found inK+ channels. 
Deletions in the first 22 residues of the Shaker K+ channel disrupt fast 
inactivation (Hoshi et al., 1990), and reapplication of a synthetic peptide 
corresponding to the first 20 residues to noninactivating mutants restores 
inactivation (Zagotta et al., 1990). This peptide is also effective on non-
inactivating K+ channels (Zagotta et al., 1990; Isacoff et al., 1991) and calcium-
activated K+ channels (Foster et al., 1992). Intriguingly, the peptide segment 
connecting domains Ill and IV of anNa+ channel, when attached to theN-
terminus of a non-inactivating K+ channel, inactivates the K+ channel (Patton et 
al., 1993). In addition, the K+ channel inactivation peptide also blocks CNG 
channels by binding to the P region (Kramer et al., 1994). These results 
indicate commonality of structure and function between Na+, K+, and CNG 
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channels for activation and inactivation gating. For a thorough review of K+ 
channel structure-function work, see Jan and Jan, 1992a. 
Similarly, among all members of the ligand-gated superfamily, the M2 
region appears to serve as the pore-forming structure. Examples below are 
illustrative of the wide variety of permeation properties governed by M2; for a 
comprehensive review, see Lester, 1992. The M2 motif was found for the ACh 
receptor via studies of mutations that altered permeation, and block by the 
open-channel blocker QX-222 (lmoto et al., 1988; Leonard et al., 1988; Charnet 
et al., 1990). A site in M2 of non-NMDA glutamate receptors governs Ca2+ 
permeability (Hume et al., 1991; Verdoorn et al., 1991), and a binding site for 
Mg2+ and MK-801 has been localized to M2 for NMDA-type glutamate 
receptors (Burnashev et al., 1992; Sakurada et al., 1993). Mutation of residues 
in M2 of the glycine receptor abolish picrotoxinin block (Pribilla et al., 1992). 
Similarly, cysteine substitutions of amino acids lining the M2 segment of the 
GABAA receptor (Xu and Akabas, 1993) and the ACh receptor (Akabas et al., 
1992) confer sulfhydryl sensitivity upon the channels. 
Structure-function work has also provided evidence for assembly 
mechanisms common to the ligand-gated superfamily. Extracellular domains 
involved in subunit assembly have been found for the glycine receptor (Kuhse 
et al., 1993) and for the ACh receptor (Yu and Hall, 1991; Verrall and Hall, 
1992). Individual residues have been localized for the ACh receptor (Gu et al., 
1991). 
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Mutations for effective structure-function analysis, however, need not 
always be in vitro mutations planned by the investigator. An exciting new 
approach was taken by Teem et al. to identify mutations that reverse the cystic 
fibrosis-causing phenotype of the CFTMF508 mutant (Teem et al., 1993). A 
portion of the first nucleotide-binding fold of yeast STE-6 a-factor mating 
peptide transporter, a member of the ABC superfamily (McGrath and 
Varshavsky, 1989), was replaced with the corresponding portion of the 
(nonfunctional) CFTMF508 c1· channel. This construct results in loss of a-
factor transport, and loss of mating phenotype. Two revertant mutations were 
identified by gain of mating efficieny and sequenced. The revertant mutations 
were introduced into the corresponding position in CFTMF508. When 
transfected into mammalian cells, functional c1· channels are generated, 
showing that these mutations suppress the defect in c1· permeability caused by 
the M<508 mutation. 
Structure-function analysis has localized drug binding sites on many 
channels. Such localization has helped identify pore domains for ligand-gated 
channels and for K+ channels, as noted above, and might eventually lead to 
ligands that are specific for individual K+ channel subtypes. Other future 
clinically relevant blockers might include subtype-specific blockers of glutamate 
receptors or transporters, neuronal acetylcholine receptors, or Ca2+ channels, to 
block neuronal excitotoxicity (Choi and Rothman, 1990; Choi, 1992). Perhaps 
inhibitors of cocaine binding to neurotransmitter transporters will yield 
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therapies for drug abuse. Understanding the mechanisms that couple opioid 
receptors to channels may lead to new analgesics or addiction therapies. 
Outside of the CNS, specific Ca2+ or K+ channel blockers could suppress 
components of immune response. Any such blockers, however, will have to be 
specific and non-global for best response. In the present day view of rational 
drug design, one requires precise atomic coordinates of the drug binding site. 
It is not yet clear whether heterologous expression and site-directed 
mutagenesis will provide structure-function information in sufficient detail to 
suggest specific new drugs that affect only specific channel subtypes. 
Limitations of mutagenesis and expression 
As with any class of experiments, the limitations and pitfalls of 
mutagenesis and expression must be kept in mind. First and foremost, 
structure-function analysis can begin only with a cloned eDNA sequence and a 
functional expression system. Differences among expression systems can 
account for major differences in findings and interpretation. For example, the 
major mutation in CFTR, the cystic fibrosis Cl- channel, is a deletion of a single 
phenylalanine residue in the first nucleotide binding fold. In mammalian cells, 
CFTR&508 is improperly processed; little (Dalemans et al., 1991) or none 
(Cheng et al., 1990) reaches the cell membrane. However, in other culture 
systems, such as Sf9 cells (Li et al., 1993) or Xenopus oocytes (Drumm et al., 
1991), the mutant protein reaches the membrane and retains Cl- channel 
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function. Uncertainty about the effect of the D.F508 mutation, by far the most 
prevalent disease-causing mutation, was cleared up by the discovery that the 
intracellular processing of CFTMF508 is sensitive to the temperature of cell 
culture (Denning et al., 1992). 
A particularly detailed analysis of functional differences among 
heterologously expressed ion channels due to the expression system is found 
for sodium channels. When expressed in neonatal rat ventricular myocytes, the 
rat brain IIA sodium channel a-subunit inactivates more quickly than when 
expressed in Chinese hamster ovary cells, though TTX sensitivity is unaffected. 
The same subunit expresses only poorly in undifferentiated BC3H-1 muscle 
cells, and not at all in Ltk· cells, even though Drosophila Shaker H4 K+ channels 
express in all four cell types (Yang et al., 1992). These results may indicate that 
cell-specific post-translational modifications, such as glycosylation or 
attachment of fatty acids, can cause functional differences; or they may point to 
the involvement of additional subunits in channel assembly (Isom et al., 1992). 
Results from heterologous expression are also easily contaminated by 
endogenous channels, and the separation of the desired channels from 
contaminating channels can be non-trivial. For example, the commonly used 
Xenopus oocyte has a strong endogenous calcium-activated c1· current (Dascal, 
1987) and a large amount of nonselective stretch-activated cation channels 
(Yang and Sachs, 1990). These endogenous channels complicate experiments 
dealing with pathways involving Ca2+ at the whole-cell level or experiments 
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dealing with cation channels at the single-channel level (Vernino et al., 1992). 
There is also the possibility of cryptic channels that only appear upon 
heterologous expression of another protein. Such cryptic channels may result 
unexpectedly from expression cloning assays. One such activator of an 
endogenous oocyte channel is the protein lc1n· lc1n was cloned by expression in 
Xenopus oocytes and was originally thought to be a cl- channel itself 
(Paulmichl et al., 1992). Later work, however, showed that Icln localizes to the 
cytosolic fraction, not the membrane fraction (Krapivinsky et al., 1994), and that 
the c1· current due to its expression is likely due to a hypotonicity-activated 
current endogenous to the oocytes (Ackerman et al., 1994). 
Another example of unexpected results from expression in oocytes is the 
small protein termed either IsK or MinK. IsK, cloned by functional expression 
in Xenopus oocytes (Takumi et al., 1988), produces a slowly activating voltage-
sensitive K+ conductance when expressed either in oocytes or in mammalian 
cells (Freeman and Kass, 1993). The endogenous conductance most similar to 
IsK is in ventricular muscle (Varnum et al., 1993; Freeman and Kass, 1993). Its 
gating (Takumi et al., 1991) and selectivity (Goldstein et al., 1991) are altered 
by point mutations, good evidence that IsK itself is the K+ channel. In other 
work, however, purified IsK displays no observable channel activity when 
incorporated into bilayers (Lesage et al., 1993), possibly because IsK has an 
unusually low single-channel conductance. Furthermore, recent work shows 
that IsK has the capacity to produce both K+ and Cl- currents with different 
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pharmacology when expressed in oocytes, depending on the cRNA 
concentration of IsK injected (Attali et al., 1993). Mutagenesis reveals that 
different domains of IsK are responsible for induction of the K+ and the Cl" 
current. Most intriguing, mutants producing only c1· channel activity act as 
dose-dependent antagonists of mutants producing only K+ channel activity, as 
though the heterologously expressed IsK (now also termed IsK,Cl by Attali et 
al., 1993) is binding to a pool of endogenous subunits, present in limiting 
amounts, that can participate in assembly of either K+ or c1· channels. 
When a mutant protein is finally expressed in a heterologous system, 
there always remains the ambiguity of whether changes in phenotype are due 
to the actual residue(s) mutated, or rather to allosteric interactions propagated 
through the protein to a domain different from the one mutated. In the 
absence of crystal structures, such objections to structure-function can never be 
totally dispelled. However, multiple mutations can be assayed to show an 
internally consistent story. For example, deletion of the N-terminal domain of 
the Shaker channel removes the inactivation gate (Hoshi et al., 1990). In 
addition, reapplication of the corresponding peptide restores inactivation in a 
dose-dependent manner, and point mutations in the reapplied peptide render 
the peptide ineffective (Zagotta et al., 1990). Moreover, the Shaker ball peptide 
acts as an open-channel blocker (Demo and Yellen, 1991), and residues have 
been found at the putative mouth of the channel corresponding to the receptor 
for the ball (Isacoff et al., 1991). In the absence of high-resolution structural 
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data, confidence in the specifity of results of structure-function work often 
resides either in additive effects of multiple mutations or in multiple effects of 
a single mutation. 
There are also intrinsic limitations to the present techniques of in vitro 
mutagenesis and heterologous expression. There are but 20 naturally occurring 
amino acids, and incorporation of an unnatural amino acid into a system 
suitable for analysis is very laborious. Moreover, the peptide backbone cannot 
be mutated, only the side chains. Fortunately, major roles for the peptide 
backbone seem unlikely, since differences in selectivity and activation among 
ion channels evolved through modifications in side-chains, and not in the 
backbone (but see Heginbotham et al., 1994). Mutations can seldom address 
coupling mechanisms--how ligand binding is coupled to channel opening, or 
what conformational changes open a voltage-activated channel. Most irritating, 
many in vitro mutations do not express, for unknown reasons, even when 
wild-type constructs do. 
Future directions 
With so many channels already taken apart, residue by residue, where 
will structure-function go next? First, whole families of channels have yet to 
be cloned, as well as some intriguing individual channels within families . 
Channels gated by mechanotransduction, for example, represent an entire 
family of channels important for cellular volume regulation and for hearing 
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sensory transduction. Stretch channels are ubiquitous (Sachs, 1991), and their 
biophysical properties are well-described, but the molecular bases for their 
activation are unknown. The hair cell mechanotransduction channel, for 
example, appears to be gated by direct physical pull on an activation gate 
(Hudspeth and Gillespie, 1994). What are the residues involved in this novel 
gating mechanism, and what residues make up the activation gate? Stretch 
channels in oocytes are known to be nonspecific cation channels (Yang and 
Sachs, 1990), while many volume-regulated channels are Cl--selective (McCarty 
and O'Neil, 1992). What insights will the primary sequence, when deduced, 
give about the nature of ion selectivity? Stretch channels are still awaiting a 
clean system for expression cloning; their very abundance has hindered their 
study. Note, however, that the recently cloned amiloride-sensitive sodium 
channel shares homology with C. elegans gene products involved in 
mechanotransduction (Canessa et al., 1994). This implies that it may be a 
stretch channel. 
In addition to the stretch channels, channels activated by Ca2+ need 
further exploration. Ca2+-activated K+ channels are especially intriguing 
because some of them have high conductances, well over 100 pS. This 
conductance has made possible detailed studies of the pore (Eisenman et al., 
1986). Families of clones, from the Drosophila slo locus (Atkinson et al., 1991; 
Adelman et al., 1992), and mammalian homologs (Butler et al., 1993), have been 
reported, but no Ca2+-activated Cl- channel is cloned. Volume-activated Cl-
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conductances are important for immunological response (Lewis et al., 1993) 
and for regulatory volume decrease in a variety of cell types (McCarty and 
O'Neil, 1992). Cloning of the channels involved may resolve a number of 
issues, including whether volume-activated channels are activated directly by 
membrane stretch or by some other mechanism, such as dilution of a 
cytoplasmic regulatory component. Another uncloned c1· channel is the 
histamine-gated cl- channel, a presumed member of the ligand-gated 
superfamily (Hardie, 1989). 
Molecular biology has uncovered a bewildering array of sequence 
variations among channels, but the in vivo functions of different subtypes 
remain largely unknown. Acetylcholine receptors, glutamate receptors, and K+ 
channels are all large families that may still contain uncloned members. 
Heterologous expression has found significant functional differences among 
channel subtypes, such as between the R/Q subtypes of AMPA glutamate 
receptors (Hume et al., 1991; Verdoorn et al. , 1991; Sommer et al., 1991). How 
are these channel subtypes spatially organized? How are these channel 
subtypes the bases for cellular function? To answer these more cellular 
questions, structure-function analysis will move towards changing the 
individual components of signaling pathways, rather than changing the 
residues of individual channels. Tools include not only mutagenesis, but also 
gene knockout and antisense technology. Such work has already begun. 
Transfection of Na+ and K+ channels can reconstruct the properties of an entire 
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neuron (Hsu et al., 1993), albeit a rather simple one. Analysis of the cystic 
fibrosis knockout mouse has confirmed defective regulation of an outward 
rectifier Cl-channel separate from the cystic fibrosis gene product (Gabriel et 
al., 1993). 
In the future, primary physiology and biochemistry will uncover more 
transduction pathways. Knockout of the individual components, or more 
subtle manipulation of the individual components through mutagenesis and 
expression, will reveal the function of each piece. Perhaps knockout of 
dopamine receptors will lead to a Parkinson's-like phenotype. With the 
cloning of the G-protein-activated potassium channel KGA, or GIRK1 (Dascal 
et al., 1993; Kubo et al., 1993) the components of the famous cardiac vagusstoff 
signaling pathway have all been cloned. What will mutation or antisense 
knockout of the receptors and channels involved reveal about heartbeat 
regulation? 
Structure-function work on cloned ion channels will take a quantum 
leap forward with the advent of high-resolution structural data. Although the 
time scale for crystallization of a full ion channel is not predictable, we can 
hope for timely high-resolution structures of individual domains, especially 
soluble domains. Then past domain analyses will be tested, and future 
mutations will be guided and improved exponentially by knowledge of the 
actual structures involved. Until now, channel biologists have been working 
with a black box; with crystal structures, work will be at the level of the 
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mutagenesis done on hemoglobin. The excitement generated by the dissection 
of individual channels will continue and increase, as structure-function analysis 
is applied to increasingly complex systems. 
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Figure 1. Predicted transmembrane topologies of ion channel families. Shaded 
background represents the plasma membrane; dark rectangles are putative 
transmembrane a-helices. N and C indicate the terminii of the amino acid 
sequence. A, single subunit of a voltage-gated K+ channel. P indicates the 
pore region; jagged structure signifies putative ~-strand. B, voltage-gated Na+ 
or K + channel topology. C, cyclic nucleotide-gated channel. D, inward rectifier 
K + channel. E, ligand-gated channel. Left, side view of a single a-subunit. 
Ligand-binding domain is extracellular; M2 pore-lining domain is shown as a 
rounded rectangle. Right, view of the full receptor, made up of five subunits, 
along an axis perpendicular to the plane of the membrane. Each circle 
represents a transmembrane domain; M2 domain is shaded. Small shaded 
circles represent ligand-binding domains. F, cystic fibrosis transmembrane 
conductance regulator c1· channel (CFTR). NBF1 and NBF2, nucleotide 
binding folds 1 and 2. R, R-domain. G, ClC c1· channel. D13, cytoplasmic 
hydrophobic domain. 
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Figure 1. Predicted transmembrane topologies of ion channel families. Shaded 
background represents the plasma membrane; dark rectangles are putative 
transmembrane a-helices. Nand C indicate the terminii of the amino acid 
sequence. A, single subunit of a voltage-gated K+ channel. P indicates the 
pore region; jagged structure signifies putative ~-strand. B, voltage-gated Na+ 
or K+ channel topology. C, cyclic-nucleotide gated channel. D, inward rectifier 
K+ channel. E, ligand-gated channel. Left, side view of a single a-subunit. 
Ligand-binding domain is extracellular; M2 pore-lining domain is shown as a 
rounded rectangle. Right, top view of the full receptor, made up of five 
subunits. Each circle represents a transmembrane domain; M2 domain is 
shaded. Small shaded circles represent ligand-binding domains. F, cystic 
fibrosis transmembrane conductance regulator chloride channel (CFTR). NBFl 
and NBF2, nucleotide binding folds 1 and 2. R, R-domain. G, ClC chloride 
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ABSTRACT 
The gene defective in cystic fibrosis encodes a Cl- channel, the cystic fibrosis 
transmembrane conductance regulator (CFTR). CFTR is blocked by 
diphenylamine-2-carboxylate (DPC), when applied extracellularly at mM 
concentrations. We studied the block of CFTR expressed in Xenopus oocytes by 
DPC or by a closely related molecule, flufenamic acid (FFA). Block of whole-
cell CFTR currents by bath-applied DPC or by FFA, both at 200 pM, requires 
several min to reach full effect. Blockade is voltage dependent, suggesting 
open-channel block: currents at positive potentials are not affected but 
currents at negative potentials are reduced. The binding site for both drugs 
senses ~40% of the electric field across the membrane, measured from the 
inside. In single-channel recordings from excised patches without blockers, the 
conductance was 8.0 ± 0.4 pS in symmetric 150 mM CL A subconductance 
state, measurin.g approximately 60% of the main conductance, was often 
observed. Bursts to the full open state lasting up to tens of seconds were 
uninterrupted at depolarizing membrane voltages. At hyperpolarizing 
voltages, bursts were interrupted by brief closures. Either DPC or FFA (50 pM) 
applied to the cytoplasmic face or to the extracellular face of the channelled to 
an increase in flicker at V m = -100 m V and not at V m = + 100 m V, in agreement 
with whole-cell experiments. DPC induced a higher frequency of flickers from 
II-3 
the cytoplasmic side than the extracellular side. FFA produced longer closures 
than DPC; the FFA closed time was roughly equal (-1.2 ms) at -100 mV with 
application from either side. In cell-attached patch recordings with DPC or 
FFA applied to the bath, there was flickery block at Vm = -100 mV, confirming 
that the drugs permeate through the membrane to reach the binding site. The 
data are consistent with the presence of a single binding site for both drugs, 
reached from either end of the channel. Open-channel block by DPC or FFA 




The gene that is defective in cystic fibrosis encodes the cystic fibrosis 
transmembrane conductance regulator (CFTR); secondary structure predictions 
suggested that the protein may serve as an ion channel (Riordan, Rommens, 
Kerem, Alon, Rozmahel, Grzelczak, Zielenski, Lok, Plavsic, Chou, Drumm, 
Iannuzzi, Collins, and Tsui, 1989). Heterologous expression of the CFTR gene 
in epithelial and non-epithelial cells indicates that this gene encodes a Cl-
channel activated by the cAMP-protein kinase A pathway (Gregory, Cheng, 
Rich, Marshall, Paul, Hehir, Ostedgaard, Klinger, Welsh, and Smith, 1990; Rich, 
Anderson, Gregory, Cheng, Paul, Jefferson, McCann, Klinger, Smith, and 
Welsh, 1990; Anderson, Rich, Gregory, Smith, and Welsh, 1991; Kartner, 
Hanrahan, Jensen, Naismith, Sun, Ackerley, Reyes, Tsui, Rommens, Bear, and 
Riordan, 1991). The characteristics of the channel--low conductance, linear 
current-voltage relation, and selectivity for Cl- over f--match those of the Cl-
permeability pathway now believed to be defective in cystic fibrosis (Welsh, 
1990; Cliff, Schoumacher, and Frizzell, 1992). 
This study concerns the permeation properties of the CFTR channel, as 
probed by small blocking molecules. By investigating the interaction of an 
open channel blocker with the pore of the protein, we hope to improve our 
II-5 
understanding of CFTR function. 
Several classes of molecules have been developed as inhibitors of 
various kinds of Cl- channels. The disulfonic stilbenes, first developed as 
inhibitors of the red blood cell anion exchanger, block the outward rectifier Cl-
channel of epithelial cells (Singh, Afink, Venglarik, Wang, and Bridges, 1991; 
Tilmann, Kunzelmann, Probe, Cabantchik, Lang, Englert, and Greger, 1991). 
The phenoxyacetic acid derivative, indanyloxyacetic acid 94, was developed as 
a probe for isolation of an epithelial cl- channel (Landry, Reitman, Cragoe, and 
Al-Awqati, 1987). Anthracene-9-carboxylate is a useful inhibitor of the voltage-
gated cl- channel of skeletal muscle, but is ineffective on the cl- channels of 
canine trachea and shark rectal gland, two chloride-secreting tissues (see 
Cabantchik and Greger, 1992). The arylaminobenzoates were developed by 
Greger and co-workers, who showed that diphenylamine-2-carboxylate (DPC) 
inhibited the basolateral Cl- channel of renal thick ascending limb cells 
(DiStefano, Wittner, Schlatter, Lang, Englert, and Greger, 1985). DPC and its 
congeners are effective inhibitors of several epithelial cl- channels 
(Wangemann, Wittner, DiStefano, Englert, Lang, Schlatter, and Greger, 1986; 
Bijman, Englert, Lang, Greger, and Fromter, 1987; Tilmann, Kunzelmann, 
Frobe, Cabantchik, Lang, Englert, and Greger, 1991). 
The disulfonic stilbene, DIDS, is not an effective blocker of CFTR when 
applied to the bath (Kartner et al. , 1991; Cunningham, Worrell, Benos, and 
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Frizzell, 1992). In contrast, DPC has been used in several CFTR heterologous 
expression studies, in which it inhibited whole-cell currents at fairly high 
concentrations (Rich et al., 1990). However, the single-channel and molecular 
bases of blockade of CFTR have not yet been described. In this report, we 
describe results from our studies of CFTR using two closely-related 
arylaminobenzoates (DPC and flufenamic acid, Fig. 1) as probes to investigate 
permeation properties of the channel. We find that both DPC and flufenamic 
acid (FFA) block the CFTR channel in a voltage-dependent manner, by 
introducing brief closures in the open channel bursts. Analyses of the voltage 
dependence and kinetics of drug-channel interactions allow us to suggest 
possible mechanisms for blockade of the pore by DPC and FF A. These results 
will serve as a basis for future studies involving site-directed mutagenesis of 
proposed pore-lining segments of the CFTR protein. 
Portions of these data have been published previously in abstract form 
(McCarty, Cohen, Quick, Riordan, Davidson, and Lester, 1992; McDonough, 
McCarty, Riordan, Davidson, and Lester, 1993). 
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METHODS AND MATERIALS 
Preparation of oocytes and cRNA 
Stage V - VI oocytes from female Xenopus were prepared as described 
(Quick, Naeve, Davidson, and Lester, 1992), and incubated at 18°C in 
incubation medium (see below). For the first day after isolation, incubation 
medium also contained 5% horse serum (Quick et al., 1992). In some cases, 
horse serum was continued for several days. In all cases, however, serum was 
removed at least 8 h prior to recording. cRNA was prepared from a construct 
carrying the full coding region of CFTR in a pSP64(poly A) vector (Bear, 
Duguay, Naismith, Kartner, Hanrahan, and Riordan, 1991). Oocytes were 
injected with 1 - 2 ng or 12- 25 ng cRNA for whole-cell or single-channel 
recordings, respectively, in a volume of -50 nL. Recordings were made 48 - 96 
h after injection. In experiments using heterologous expression of the human 
beta-2 adrenergic receptor (~2-AR), 0.1 to 5 ng of this cRNA were injected along 
with CFTR. Injection of higher concentrations of ~2-AR cRNA in CFTR-injected 
oocytes led to spontaneous oscillations of holding current. This was likely due 
to spontaneous activation of the beta receptor, leading to high concentrations of 
cAMP, and could be prevented by incubation in propranolol (50 pM) for 8 h 
prior to recording. 
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Electrophysiology 
Standard two-electrode voltage clamp techniques were used to study 
whole-cell currents. Electrodes were pulled in four stages from borosilicate 
glass (Sutter Instr. Co., Novato, CA), and filled with 3 M KCL Pipette 
resistances measured 0.5 to 2.5 MQ in bath solution. Membrane voltages were 
typically held at either -30 m V or -45 m V and stepped to a series of test 
potentials by an Axoclamp 2A amplifier (Axon Instuments, Foster City, CA). 
Currents filtered at 500 Hz were stored on videotape after digitization or were 
acquired directly on-line using the Clampex program of pCLAMP (Axon) . 
DPC and FFA also block the endogenous Ca2+-activated Cl- conductance, 
but with time course and voltage dependence different from CFTR blockade. 
Blockade of the endogenous conductance was complete within 1-2 min of 
exposure, suggesting an action from the outer surface of the membrane. The 
effects of DPC and FFA were not dependent upon voltage: inward and 
outward currents were inhibited equally (data not shown). These results are 
consistent with the initial description of blockade of the oocyte channel by FFA 
and niflumic acid (White and Aylwin, 1990). It should be noted, however, that 
Wu and Hamill (1992) recently reported a slight voltage-dependence of the 
blockade of the endogenous channel in oocytes by 5-nitro-2-(3-
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phenylpropylamino) benzoic acid (NPPB), a blocker related to DPC and FFA. 
In our experiments, cAMP-activated currents were at least five times greater 
than the background currents; therefore, blockade of the endogenous channel 
produced negligible distortion in the overall effect of DPC and FFA. 
For single-channel recordings, oocytes were shaken in stripping solution 
(see below) for 15 min. The vitelline membrane was then removed manually 
using fine forceps . Recordings were performed in both cell-attached and 
excised, inside-out modes, using electrodes pulled in four stages from 
borosilicate glass (Sutter). Pipette resistances ranged from 10 to 40 MQ. Seal 
resistances ranged from 20 to - 200 GQ. Patch currents were measured with an 
Axopatch 1D amplifier (Axon) . Data were filtered at 2 - 2.5 kHz and stored on 
videotape. For subsequent analysis, records were filtered at 1 kHz with an 8-
pole Bessel filter (Frequency Devices model 902, Haverhill, MA) and digitized 
at 100 ps per point during acquisition by the Fetchex program of pClamp 
(Axon) . In the single-channel traces shown, inward currents (anions passing 
from the cytoplasm to the external solution) are shown as negative 
(downward) deflections from baseline. Voltages in single-channel experiments 
are indicated as transmembrane voltage (internal minus external) . In cell-




Whole-cell current records were analyzed using the Clampfit program of 
pClamp (Axon) . For construction of 1/V curves and for calculation of voltage 
dependence of block, data were taken from the latter half of a 75 ms step to 
each potential and averaged. The current at each potential before cAMP 
stimulation and after washout was subtracted to determine cAMP-dependent 
current. For single-channel measurements, digitized Fetchex records were 
analyzed to produce idealized records and histogram files by the IPROC 
program (Axon) (Sachs, Neil, and Barkakati, 1982; Sachs, 1983). IPROC uses a 
cubic splining function to interpolate between data points. Transition analysis 
employed an open/ closed border midway between the open and closed levels. 
The histogram files generated by IPROC were analyzed by NFITS (Island 
Products, Galveston, TX), a nonlinear least squares curve-fitting procedure. 
For calculation of open probability within a burst (P 0 ), closings longer 
than 5 ms defined the end of a burst, since longer bursts often exceeded the 
IPROC burst memory. Bursts with baseline shift or more than one channel 
were not used for P 0 calculations. System dead time was calculated and 
experimentally confirmed to be -0.3 ms for a corner frequency (Fe) = 1 kHz. 
In closed-time histograms, curve-fitting began with the first bin past the dead 
time, the bin from 0.3 to 0.4 ms. Time constants were then taken from the 
extrapolated curves. Unless noted otherwise, values given are mean± S.E.M . 
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Solutions 
The bath solution for whole-cell studies was ND96 without added Ca2+ 
salts, containing (mM): 96 NaCl; 2 KCl; 1 MgC12; 5 HEPES; pH 7.5. Incubation 
medium was ND96 with added CaC12 (1 .5 mM), Na-pyruvate (2.5 mM) and 
gentamycin (50 p.g/ ml), pH 7.5. The hypertonic stripping solution contained 
(mM): 200 monopotassium aspartate; 20 KCl; 1 MgC12; 10 EGTA; 10 HEPES-
KOH; pH 7.2. For patch-clamp experiments, the pipette contained (mM): 150 
N-methyl-D-glucamine·Cl; 0.5 MgC12; 10 TES; pH adjusted to 7.4 with Tris. 
The intracellular solution for inside-out patches contained (mM): 150 
NMDG·Cl; 1.1 MgC12; 2 Tris·EGTA; 1 MgATP (from equine muscle, <1 ppm 
vanadium); 10 TES; pH 7.4; and in some cases, 2 MgATP; and 10 NaF. Bath 
solutions were delivered by gravity feed at a rate of -3 ml / min. Intracellular 
cAMP levels were increased by application of either 1 p.M isoproterenol or the 
cAMP-elevating cocktail of (p.M): 1-10 forskolin; 10-200 dibutyryl-cAMP; and 
10-200 3-isobutyl-1-methylxanthine. Cytoplasmic (4.3 mM) and extracellular 
(7.3 mM) ethanol, cytoplasmic 10 mM NaF, and raising cytoplasmic ATP 
concentration from 1 to 2 mM had no effects on channel kinetics; these data 
were combined to form the unblocked channel data. Four mM ethanol was 
also without effect on whole-cell CFTR currents. 
When patches containing activated CFTR channels were excised into 
A TP solution, channel activity frequently ran down over the course of seconds. 
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We considered it likely that this was due to a membrane-bound phosphatase 
that reversed the phosphorylation of CFTR by protein kinase A, or perhaps 
due to intrinsic phosphatase activity of CFTR. We found that addition of 10 
mM NaF to the intracellular solution slowed, although did not prevent, this 
run-down. 
DPC and FFA were dissolved in 100% ethanol at stock concentrations of 
1.25 M and 0.15 M, respectively. 
Source of reagents 
Unless otherwise noted, all reagents were obtained from Sigma Chemical 
Co. (St. Louis, MO). TES and DPC (N-phenylanthranilic acid) were from 
Aldrich Chemical Co. (Milwaukee, WI); FFA was from Sigma. Tris was from 
Boehringer Mannheim Biochemicals (Indianapolis, IN) and serum was from 




Cyclic AMP-dependent Cl- currents were strongly activated in oocytes 
injected with CFTR and stimulated by either (1) application of cAMP-
stimulating cocktail in cells injected with CFTR alone or (2) exposure to 
isoproterenol in cells coinjected with the human ~2-AR and CFTR. In cells 
expressing ~2-AR alone or CFTR alone, exposure to 10 p.M isoproterenol did 
not lead to activation of currents significantly greater than prestimulation 
control (data not shown). Similarly, exposure of noninjected cells to the cAMP 
cocktail was without effect. 
We took steps to avoid significant contamination of our whole-cell 
records by the endogenous Ca2+-activated Cl- [Cl(ca)] channels (see Methods) . 
We used nominally Ca-free solutions and recorded only from oocytes whose 
resting conductances were low (holding current at V m = -45 m V ~ 250 nA). 
CFTR currents were easily distinguished from currents through the 
endogenous Cl(ca) channel, because (1) the latter typically showed some decay 
of outward current through time while CFTR currents were consistently time-
independent; and (2) the endogenous currents show pronounced outward 
rectification, but CFTR currents are characterized by a nearly linear 1/V 
relation. The slightly sublinear conductance of CFTR currents (see below) 
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observed in our experiments at strongly hyperpolarizing voltages probably 
arises from the lower value of cytoplasmic Cl- concentration relative to that in 
the bath_ Parenthetically, we found that prolonged clamping of oocytes at 
holding potentials more negative than -30 m V led to further decreases of 
conductance at highly negative potentials. Presumably this effect arose from 
re-equilibration of intracellular [en at the new holding potential. 
Effects of DPC on whole-cell currents 
DPC blockade of CFTR was slow and voltage dependent. Exposure of 
cAMP-activated oocytes to DPC led to reduction in inward holding current in 
two phases. The initial, fast phase was probably due to partial blockade of the 
Cl(ca) channel in addition to partial block of CFTR from the outside. The 
magnitude of this phase varied depending upon the size of the background 
Cl(ca) current. The subsequent phase required 7 - 10 min and involved a 
further decline in holding current. The extent of blockade of cAMP-stimulated 
holding current (at V m = -30 m V) after this period was 37 ± 4 % (n=6) for 200 
pM DPC and 80 ± 5 % (n=8) for 1 mM DPC. At equilibrium, DPC blockade of 
CFTR was clearly voltage dependent: there was pronounced outward 
rectification in the 1/V relation (Fig. 2). Inward currents were greatly reduced, 
while outward currents were mostly unaffected. DPC and some congeners 
block non-selective cation channels (Gogelein, Dahlem, Englert, and Lang, 1990) 
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and inhibit prostaglandin biosynthesis (Flower, 1974), thus affecting 
intracellular metabolism. These secondary actions do not affect CFTR and are 
not apparent in the oocyte system at the drug concentrations used, because 
outward CFTR currents do not change over time. The persistence of outward 
current levels also serves as an internal control to ensure that the activation 
level of CFTR had not decreased over the 7 - 10 min required for equilibrium 
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blockade. The effects of DPC were fully reversible with a 10 min wash (data 
not shown). 
The voltage-dependence of block was calculated using average current 
values from the latter half of the 75 ms voltage steps to potentials ranging from 
-100 to +80 mV. Thus, the effect of voltage upon the apparent dissociation 
constant was calculated as follows: 
I 
K0 (V) = [drug] • 
where I0 is the current level at voltage V in cAMP-activated oocytes in the 
absence of blocker and I is the current level after several min of treatment with 
drug (Fig. 3). The calculated K0 at 0 mV averaged 912 ± 60 ~M and K0 at -100 
m V averaged 237 ± 34 ~M for cells acutely exposed to 200 ~M DPC (n = 7). 
For experiments with 1 mM DPC (for instance, Fig. 3), the data gave the 
following values: K0 (0 mV) = 1116 ± 51pM and K0 (-100 mV) = 346 ± 41pM 
(n = 3). The electrical distance sensed by the blocker molecule, e, is 
proportional to the slope of the curve of K0 versus voltage. Assuming valence 
= -1 and a single binding site for DPC, we calculated an average e = 41 ± 7.0 
%, as measured from the inside. 
Effects of FFA on whole-cell currents 
Oocytes expressing CFTR currents displayed a biphasic response to 
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bath-applied 200 pM FFA. There was an initial fast block followed by a 
sizeable increase in inward current after -15 sec, contrary to the expected 
blockade (n=4, data not shown). We circumvented this secondary effect by 
injecting oocytes with 500 pmol EGTA (50 nL of a 10 mM stock, pH 8.4) 4 to 8 
h prior to recording. Assuming a volume of 1 pL per oocyte, the final EGTA 
concentration was 0.5 mM. FFA applied to EGTA-injected oocytes did not 
cause increased current. With EGTA-injected oocytes, block of CFTR currents 
was similar to DPC block: there was an initial decline over 1-2 min, followed 
by a slower decline requiring several min to reach completion. 
Release of calcium from intracellular stores, as shown to occur in some 
cell types (McDougall, Markham, Cameron, and Sweetman, 1988; Poronnik, 
Ward, and Cook, 1992) upon exposure to FFA and some congeners but not 
DPC, could have caused the secondary increase in conductance via activation 
of the Cl(ca) current. However, the effect of FFA on noninjected oocytes, or on 
CFTR-injected but unstimulated oocytes, was a simple fast block of the 
endogenous current (n = 8). We believe that the EGTA-injection result 
indicates that the secondary effect of FFA might be due to potentiation of 
CFTR activation, either by (1) an additional intracellular signaling pathway or 
(2) modification of membrane recycling at the oocyte surface. 
Like DPC, FFA blocked inward currents without large effects upon 
outward currents (Fig. 4). Block of CFTR holding current (at-30m V) by 200 
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pM FFA averaged 38 ± 7% (n = 6), as compared to 37 ± 4% for 200 pM DPC. 
The voltage-dependence of blockade was also similar to that of DPC. 
Calculated K0 (0 m V) was 1222 ± 88 pM, and K0 ( -100 m V) was 289 ± 34 pM 
(n = 6). Voltage dependence of FFA block showed that e = 41 ± 3 %, similar to 
the value for DPC. 
Single-channel recordings 
Given the long time course of block and the pronounced voltage 
dependence for DPC and FFA, we considered it likely that these drugs block 
the CFTR channel by an interaction with the pore from the cytoplasmic side of 
the channel. This notion was further investigated in patch-clamp experiments 
where drug concentrations and site of delivery could be more closely 
controlled. 
Single-channel CFTR currents were measured in oocytes activated by 
cocktail or heterologous expression of ~2-AR or both (Fig. 5). CFTR channels 
are characterized by openings lasting up to several tens of seconds, a hallmark 
which renders this channel easily distinguished from contaminating channels 
(Bear et al., 1991). In symmetrical 150 mM cl-, the single-channel conductance 
was linear for voltages ±100 mV and ranged from 6.4 to 9.3 pS, averaging 8.0 ± 
0.4 pS (n=6). This channel was never seen in noninjected or mock-injected 
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oocytes (n = 33). A subconductance state of approximately 60% the size of the 
main conductance was frequently observed at both vm = -100 and vm = +100 
m V (see for instance asterisk in Fig. 7e, below). The subconductance state 
often lasted for several seconds, though the time spent in the subconductance 
state was less than ~5% of total time. At positive V m' openings to the full 
conductance level were relatively uninterrupted. At negative V w bursts were 
highly interrupted by brief closures on a ms time scale. As shown in Fig. 5, 
the brief closures in unblocked channels are more prevalent in cell-attached 
mode, perhaps reflecting blockade by a cytoplasmic molecule which is lost 
upon excision (see Tabcharani, Chang, Riordan, and Hanrahan, 1991). In cell-
attached mode, currents reversed close to the resting potential (data not 
shown). The currents shown in Fig. 5 at V m = ±100 m V in the cell-attached 
mode, therefore, show slight outward rectification, as expected from the fact 
that internal c1· concentration is several times lower than the pipette 
concentration of 150 mM. 
Effect of cytoplasmic DPC and FFA on single-channel currents 
As expected from the whole-cell data, 200 pM DPC applied directly to 
the cytoplasmic side of an excised patch led to reversible blockade of the 
single-channel openings at V m = -100 m V, causing an increase in flicker (Fig. 6; 
II-20 
see especially the expanded traces at right). Detailed analysis of block was 
carried out with 50 pM DPC or 50 pM FFA; these concentrations produced 
more clearly resolved open and closed intervals (Fig. 7, Table I). DPC and FFA 
blockade showed the voltage dependence expected from whole-cell data 
described earlier; currents recorded at positive V m were normal, but those at 
negative V m were clearly blocked (Fig. 7). 
Fig. 8 displays open and closed time histograms for control solutions 
and for cytoplasmic application of 50 pM DPC or FFA to patches containing 
activated CFTR channels, in representative experiments; Table I summarizes 
these effects for several patches. The major point of these single-channel 
analyses is that blockade by either DPC or FFA is revealed as a decrease in 
mean open times and an increase in brief closed times. Despite the similar 
effects of DPC and FF A on whole-cell currents, the details of the kinetic action 
of these two drugs differed. There was a more pronounced increase in flicker 
with FFA as compared to DPC, resulting in a clear additional closed time 
constant. Hence, the mean closed time within a burst (-cc) for CFTR channels 
was increased much more by FFA than by DPC. The average closed time for 
unblocked channels was 0.27 ms. For cytoplasmic DPC, the closed times were 
increased, but were still fit with a single exponential (-cc). There was no 
reliable improvement in histogram fits with two exponential terms, presumably 
because the DPC-induced closures were several fold more frequent than the 
II-21 
endogenous closings and yet differed from them by less than threefold in 
average duration. In contrast, closed times with cytoplasmic FFA were much 
longer, resulting in a fit with two exponentials: one corresponding to 
unblocked channels ('tc1) and a longer constant from FFA block ('tc2). The mean 
open time within a burst was greatly reduced by cytoplasmic DPC and FFA. 
However, mean open times showed no striking differences between drugs 
(Table I). Therefore, DPC and FFA produced roughly equal frequency of 
flickers, when applied from the cytoplasmic side. 
Effect of extracellular DPC and FFA on single-channel currents 
Because we interpreted the fast component of whole-cell block by DPC 
and FFA to be due to block from outside of the cell, we also studied single 
channels in excised, inside-out patches with DPC or FFA in the pipette (i.e., 
bathing the external face of the channel). At 50 pM, neither drug reduced the 
open-channel conductance when applied from the outside. Both drugs caused 
a substantial increase in flicker at Vm = -100 mV (Fig. 9). Extracellular FFA 
blocked the channel more markedly than DPC (Fig. 9). The bursts with FFA in 
the pipette solution were more frequently interrupted by closures, some as 
long as several ms. Closures of this duration were not apparent with DPC. 
Dwell time analysis of extracellular DPC and FFA on single-channel 
currents are illustrated for representative patches in Fig. 10 and summarized in 
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Table I. From the pipette, FFA clearly induced longer closed times than did 
DPC. As was the case for cytoplasmically-applied drugs, closed time 
distributions with DPC are fit with one exponential while closed time 
distributions with FFA are fit with two exponentials. The open time 
distributions show that both DPC and FFA reduced the mean open time from 
8.23 ms in the absence of blockers to 2.5 to 3 ms in the presence of blockers, 
with no significant difference between DPC and FFA. 
Permeation of bath-applied DPC and FFA through the membrane 
The slow phases of block by DPC and FFA in whole-cell mode implied 
that both blockers were membrane permeant. Cell-attached channels were 
more flickery than excised channels (Fig. 5), vitiating quantitative analysis of 
additional block by DPC or FFA. Nonetheless, to confirm that DPC can 
permeate through the plasma membrane to block CFTR from the inside, we 
activated channels in the cell-attached mode; the oocyte was then exposed to 
200 }1M DPC in the bath solution. After several min, channel openings were 
clearly interrupted at Vm = -100 (Fig. 11), but not at Vm = +100 mV (data not 
shown). FFA applied to the bath (50 }1M) also blocked in the cell-attached 
mode (Fig. 11). Because the drug did not have access to the external side of 
the channels in the patch in this configuration, these results show that drug 
molecules can cross the 
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membrane from the bath and access their binding site from the cytoplasmic 
side of the channel. 
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DISCUSSION 
The gene that is defective in cystic fibrosis encodes a c1· channel which 
is regulated by the cAMP /protein kinase A pathway. That the protein itself is 
a c1· channel is indicated by the findings that: 1) individuals carrying mutant 
CFTR gene alleles often show decreased c1· transport in affected tissues 
(Quinton, 1983; Boat, Welsh, and Beaudet, 1989); 2) expression of the CFTR 
gene in cells from a variety of non-epithelial and CF epithelial sources results 
in the appearance of a cAMP-activatable c1· conductance of specific character 
(Anderson et al., 1991b; Bear et al., 1991; Kartner et al., 1991; Cunningham et 
al., 1992); 3) site-directed mutations in the CFTR eDNA result in discrete 
changes in c1· channel function (e.g., Anderson, Gregory, Thompson, Souza, 
Paul, Mulligan, Smith, and Welsh, 1991; Cheng, Rich, Marshall, Gregory, 
Welsh, and Smith, 1991; Rich, Gregory, Anderson, Manavalan, Smith, and 
Welsh, 1991); and 4) purified CFTR protein provides functional c1· channels 
upon incorporation into planar lipid bilayers (Bear, Li, Kartner, Bridges, Jensen, 
Ramjeesingh, and Riordan, 1992). 
The present study characterizes the blocking action of two 
arylaminobenzoates: diphenylamine-2-carboxylate (DPC) and its derivative, 
flufenamic acid (FFA). Both DPC and FFA block CFTR in a voltage-dependent 
manner, by mechanisms to be discussed below. Thus, DPC and FFA will be 
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useful as probes to characterize the pore of the CFTR channel. 
In pioneering studies on heterologous expression of the CFTR gene, 3 
mM DPC caused blockade of Cl- currents in CF airway epithelial cells, CHO 
cells, and HeLa cells transfected with CFTR (Rich et al., 1990; Anderson et al, 
1991b ). Blockade was not immediate, and voltage dependence was not 
investigated. 5-nitro-2-(3-phenyl-propylamino) benzoic acid (NPPB), also 
blocks the CFTR-like channel found in pancreatic duct cell apical membranes 
(Gray, Pollard, Harris, Coleman, Greenwell, and Argent, 1990), T84 cell 
membranes (Tabcharani, Low, Elie, and Hanrahan, 1990), and Xenopus oocytes 
injected with mRNA from shark rectal gland (Sullivan, Swamy, and Field, 
1991). In contrast, both DPC and NPPB were only marginally effective at 
blocking CFTR expressed in oocytes in one study (Cunningham et al., 1992). 
However, this contradictory finding may be due to fact that Cunningham et al. 
(1992) determined cAMP-dependent currents by stepping the voltage to 80 mV 
depolarized from the resting potential. Hence, only outward currents were 
measured, and our results show that DPC is not an effective blocker of 
outward currents. We have found no reports on blockade of CFTR by FFA. 
In contrast to block of CFTR by arylaminobenzoates, disulfonic stilbenes 
appear to be ineffective. CFTR currents are insensitive to block by 4,4'-
diisothiocyanatostilbene-2,2' -disulfonic acid (DIDS) upon expression in oocytes 
(Cunningham et al., 1992) and Sf9 cells (Kartner et al., 1991). The small-
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conductance CFTR-like channels in pancreatic duct cell apical membranes 
(Gray et al., 1990) and T84 cell membranes (Tabcharani et al., 1990) were also 
insensitive to block by DIDS. However, disulfonic stilbenes are effective 
blockers of the intermediate conductance outward-rectifier anion channel of 
epithelia (Singh et al., 1991; Tilmann et al., 1991) and the Ca2+-activated cl-
channel in several cell types. In oocytes, 50 pM DIDS blocked the background 
conductance in a voltage-independent manner (Cunningham et al., 1992). 
Voltage-dependent block of macroscopic currents 
Whole-cell currents in CFTR-injected oocytes activated by cAMP were 
inhibited by both DPC and FFA. Blockade by both drugs was strongly voltage 
dependent: the K0 decreased as transmembrane potential became more 
negative at a rate of e-fold per ~60 m V. This voltage dependence contrasts 
with the much weaker, voltage-independent blockade of the endogenous Ca2+ -
activated Ct channels by DPC. CFTR block by DPC and FFA required several 
min to reach maximal effect. Blockade occurred in two phases: a fast phase 
due to partial block from the external side of the channel, followed by a slower 
phase, presumably due to block from the cytoplasmic side after drug 
permeation through the plasma membrane. The voltage dependence of 
blockade, as determined by the variation in K0 with voltage, indicates that 
DPC and FFA molecules sense a similar fraction (0.4- 0.5) of the electrical field 
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across the membrane and hence may share a common binding site. 
Voltage-dependent block of single-channel currents 
Single-channel data indicate that both DPC and FFA block CFTR by 
increasing the frequency of brief non-conducting periods: the current traces 
become more flickery without a reduction in the apparent single-channel 
conductance. Thus, DPC and FFA may be classified as "intermediate" drugs, in 
the terminology of Hille (1992), regarding the kinetics of drug/receptor 
interaction. Interestingly, the subconductance state showed much less flicker 
than the main state upon application of drugs to either side (data not shown). 
This effect has not been studied systematically. 
As indicated in Table I, the block of DPC and FFA is revealed both by 
(a) an increase in average closed times and (b) a decrease in average open 
times in the presence of blockers. In Table I, the average closed times for all 
four drug configurations were significantly different from closed times for 
unblocked channels (p < 0.05, unpaired t-test). The same is true for average 
open times, with the exception of open times with external DPC, the least 
potent blocking condition (p = 0.051). Single-channel measurements confirm 
the whole-cell data: the flickery block occurs only at negative membrane 
potentials. Block of single channels by DPC was reversible, as was the case for 
whole-cell measurements. Increasing order of potency of block at a given 
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concentration and voltage is as follows: DPC applied externally, DPC 
internally, FFA internally, and FFA externally. 
Open-channel block 
Two general classes of block involve either (1) direct block of conduction 
due to binding within the pore itself or (2) allosteric inhibition due to binding 
outside the pore. That FFA and DPC blockade is voltage dependent, with an 
apparent binding site 40 - 50% of the electrical distance from the cytoplasmic 
face, suggests that the blockade actually occurs within the channel. In 
addition, the blocked single-channel traces resemble classic open-channel block; 
brief blocked times would represent the residence time of the blocker on its 
site. We have no formal proof of this mechanism, however; future experiments 
will test this suggestion by examining antagonism of the blockade by permeant 
ions. 
Assuming for the moment that open-channel block is the mechanism, a 
simple kinetic model may be discussed. A drug molecule, T, binds to a single 
class of receptor sites, R, as follows: 
T+R ~ TR 
where k1 is the second-order bimolecular rate constant for binding, k_1 is the 
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first-order unimolecular rate constant for dissociation, and K0 is the 
equilibrium dissociation constant for the drug-receptor complex. Because [T]k1 
= 1/'t0 and k_1 = 1/-rc , we can estimate the apparent dissociation constant from 
the single-channel data at a given drug concentration and at a given membrane 
voltage, K0 (V) as 
Applying values for 't0 and -rc1 or -rc2 at Vm = -100 mV from Table I, we 
calculate values for K0 ( -100) under the following conditions: for DPCext1 345 
pM; for DPCcyto' 175 pM; for FFAcyto' 105 pM; and for FFAext1 85 pM, where the 
subscripts ext and cyto refer to drugs in the extracellular and cytoplasmic 
solutions, respectively. This quantitative order of potency agrees with the 
perceived order of potency listed above and with the similarity in values for 
K0 (-100 mV) measured from block of whole-cell currents, which averaged 237 
± 34 pM and 289 ± 33 pM for DPC and FFA, respectively. The single-channel 
data suggest that FFA binds 2- 3 times more tightly than DPC; the whole-cell 
data suggest roughly equal equilibrium dissociation constants. We believe that 
the single-channel data give the more accurate picture because the drug 
concentrations are more directly controlled in excised-patch experiments. 
The similarity in 't0 values for DPC and FFA in all four configurations 
suggests that k1 :::: 6 x 10
7 s·1, close to the value of 2 x 107 s·1 determined for 
open-channel blockers of the acetylcholine receptor channel (Charnet, Labarca, 
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Leonard, Vogelaar, Czyzyk, Gouin, Davidson, and Lester, 1990). The most 
striking difference in kinetic effects between DPC and FFA in the four 
configurations is seen in the closed time constants. FFA apparently remains 
bound to its site several times longer than does DPC. 
Access through the conduction pathway? 
How do the blockers reach their binding sites? The most important 
constraint for modeling this process is that the blockers appear to reach their 
binding site from either side of the membrane; furthermore, kinetics of FFA, 
which yields equal voltage dependence and residence time with application 
from either side, suggest that the binding site is the same from either side. 
Possible routes of access are (1) through the conducting pathway, or (2) 
through the membrane itself. There are precedents for both routes (Hille, 
1992). 
Permeant blocker; asymmetric energy barriers. 
One possible view of block in the CFTR channel invokes permeant 
blockers and asymmetric energy barriers, similar to more detailed models that 
explain block of Na+ channels by protons (Woodhull, 1973) and block of retinal 
cyclic nucleotide-gated cation channels by divalent cations (Zimmerman and 
Baylor, 1992). In its simplest form, this model would incorporate two barriers 
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(with energy peaks Eouter and E;nner ) flanking one well located at a distance -0.4 
- 0.5 from the inside edge. The well depth for DPC is shallower than for FFA, 
accounting for the longer residence time of FFA (longer closed time constant, 
'tc). At zero transmembrane potential, the external energy barrier Eouter is less 
than Einner· At V m = -100 m V, the inner and outer energy barriers experienced 
by a blocker molecule are of equal height, so that the drugs can reach the 
binding site equally well from either side, accounting for the similar forward 
binding rates, k1. Regardless of the side of drug application, upon unbinding 
at negative V m the (negatively charged) drug molecules are more likely to exit 
down the electrical gradient, over the external barrier. At positive membrane 
voltages, the internal barrier is lowered to the point where externally applied 
drug rapidly exits to the internal solution down the electrical gradient, 
resulting in little or no blockade. Internally applied drugs cannot overcome the 
larger internal barrier against the electrical gradient. The whole-cell data do 
show a small degree of block by both DPC and FFA at depolarizing voltages 
(see Fig. 3 and 4), which could represent very short-lived residence of the 
blocker on the binding site; this brief block would not be resolved in our 
single-channel measurements. 
The asymmetric barrier model explains the counterintuitive result that 
externally applied DPC and FFA are each capable of entering the channel and 
reaching their binding site against the applied membrane field. Similarly, Ca2+ 
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blocks the retinal cyclic nucleotide-gated channel although the apparent 
electrical gradient does not favor its entry into the channel (Zimmerman and 
Baylor, 1992). 
Block due to lock-in 
If the pore contains multiple anion binding sites, chloride occupancy of 
binding sites could impede dissociation of FFA or DPC from the pore. Such a 
"lock-in" phenomenon has been studied for the calcium-activated potassium 
channel of rat skeletal muscle, most recently by Neyton and Miller (1988a,b). 
However, CFTR channels are characterized by a low conductance and a low 
degree of size selectivity, implying that there may not be multiple anion 
binding sites within the pore. 
Regardless of the exact mechanism for blocker binding, these models 
suggest that DPC and FFA are permeant blockers: they can exit in the opposite 
direction from their entrance. Their action is thus more complex than that of 
quaternary ammonium compounds at nicotinic acetylcholine receptors or 
voltage-gated Na+ channels. 
Access through the lipid phase? 
Possibly the drugs do not reach their binding sites through the 
conduction pathway from the external surface, but rather through the 
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membrane phase. The membrane route might involve the uncharged form of 
the drugs. The charged form of the drugs would be the blocking form so that 
the observed voltage dependence would still be expected. This mechanism 
would be tested with measurements of pH dependence. 
DPC vs. FFA 
We consider it likely that the major interaction between the drug 
molecules and the walls of the pore involves the negative charge of the 
carboxylate moiety. However, kinetic differences between FFA and DPC 
indicate that substitution of a trifluoromethyl group influences binding energy, 
either through a direct interaction of the CF3 group with the channel or 
through an altered charge distribution on FFA as compared to DPC. 
FFA blocked whole-cell currents somewhat faster than DPC; similarly, 
externally applied FFA blocks single channels more effectively than externally 
applied DPC. The difference in K0 values between whole-cell and single-
channel measurements is most likely due to the presence of blockers on both 
sides of the membrane in the whole-cell experiments, counteracting the 
difference in sidedness observed in single-channel experiments. We do not 
know the exact intracellular concentration of drugs even after prolonged 
incubation, although block of CFTR in cell-attached patch mode by bath-
applied DPC and FFA indicates that both drugs are capable of crossing the 
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membrane. The mechanism of voltage-dependent block by FFA and DPC 
needs to be addressed more fully in future experiments employing a wider 
range of pH, permeant ion concentrations, and membrane potentials. It is also 
of interest to determine whether site-directed mutations of the CFTR gene can 
be identified that alter the blocking process. Voltage dependent blockade of 
CFTR channels by FFA and DPC constitutes a promising tool for structure-
function studies of CFTR. 
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Table I. Kinetic effects of 50 p.M DPC and FFA in excised patches at V m =-
100 mV. 
DPC DPC FFA FFA 
Unblocked" Cytoplasmic Pipette Cytoplasmic 
Pipette 
----
't0 (ms) 8.23 ± 2.17 ± 3.16 ± 2.42 ± 2.37 
± 
1.4 0.43 0.56 0.41 0.10 
'tel (ms) 0.27 ± 0.62 ± 0.46 ± 0.28 ± 0.37 
± 
0.01 0.075 0.05 0.03 0.08 
'tc2 (ms) 1.11 ± 1.41 
± 
0.05 0.12 
Po+ 0.94 ± 0.69 ± 0.80 ± 0.75 ± 0.70 
± 
0.01 0.07 0.03 0.03 0.02 
n 6 4 3 4 3 
Time analyzed (s) 
739 161 160 388 
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1020 
·unblocked values combine data from all controls in the presence and absence 
of ethanol (7.3 mM in the pipette and 4.3 mM in the cytoplasm), 1 or 2 mM 
ATP, and 10 mM NaF, all of which had no effect. 
+values for P0 are measured within a burst. The data presented exclude two 
records where it could not be determined: one each for FFA cytoplasmic and 
FFA pipette. 
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Figure 1. Molecular structures of the two blockers used in this study: 
diphenylarnine-2-carboxylic acid (DPC) and flufenarnic acid (FFA). FFA differs 
from DPC only with the addition of a trifluorornethyl group meta to the amine. 
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Figure 2. Blockade of whole-cell CFTR currents by 200 J.1M DPC. A. 
Membrane currents elicited by stepping from the holding potential of -45 m V 
to a series of test potentials from -100 mV to +80 mV, at 20 mV increments. 
Potential was held at the new value for 75 ms before returning to the holding 
potential. Capacitive currents have been subtracted. The dashed line in each 
trace indicates the zero-current level. Top: control currents measured before 
cAMP-activation. Middle: CFTR currents measured after application of cyclic 
AMP-stimulating cocktail. Bottom: activated CFTR currents measured 8 min 
after exposure to 200 p.M DPC. All traces are from the same cell. Middle and 
bottom traces are not background-subtracted. B. Current-voltage (1/V) 
relation for cAMP-dependent CFTR currents (open circles) and blocked currents 
(filled circles) after subtraction of control currents. Data points are from the 
average currents measured during the latter half of the voltage steps in A . 
Note the blockade of inward currents induced by DPC. 
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Figure 3. Voltage dependence of blockade by 200 pM DPC (filled circles) or 
by 1 mM DPC on a different cell (open circles). A. Extent of blockade as a 
function of voltage. I is the current measured during exposure to drug, and 10 
is the current measured in the absence of drug. B. Effect of membrane voltage 
on the affinity of DPC for the channel. K0 was calculated according to the text. 
The line shown is the regression line. Some data points at voltages near the 
reversal potential (0 and -20 m V) were omitted from the analysis. 
Figure 4. 
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Blockade of CFTR currents by bath application of 200 p.M FF A. 
A. Current-voltage relations determined as in Figure 2. Shown are cAMP-
dependent CFTR currents (open circles) and FFA-blocked currents (filled circles). 
B, C. l/10 and K0 as functions of voltage, respectively. 
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Figure 5. Comparison of single-channel currents measured in cell-attached 
and excised, inside-out patches, at hyperpolarizing or depolarizing voltages. 
Left: Currents measured in cell-attached configuration, with membrane 
potential (Vrn) equal to +100 mV (top) and -100 mV (bottom). Right: Currents 
measured in excised, inside-out patches, with Vrn = +100 mV (top) and -100 mV 
(bottom). Traces are all from the same patch. Each trace shows 0.6 s of 
recording. The solid line indicates the closed level and the dashed line 
indicates the open level measured in excised mode. 
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Figure 6. Reversibility of blockade by DPC applied to the cytoplasmic 
surface in excised, inside-out patches. The patch was excised directly into 
intracellular solution containing 200 pM DPC. Membrane potential (V m) = -100 
m V. A. Currents measured in the presence of DPC in the cytoplasmic 
solution. B. Washout of the DPC returned CFTR currents to the unblocked 
condition. Expanded traces at right are taken from the region indicated by the 
short bar above the unexpanded trace. The horizontal line indicates the closed 
level in both expanded and unexpanded traces. 
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Figure 7. Effect of DPC and FFA at the cytoplasmic surface of excised, 
inside-out patches. A-C. Vm = +100 mV. A. No added blockers. B. 
Cytoplasmic solution contained 50 pM DPC. C. Cytoplasmic solution 
contained 50 pM FFA. D-F. Vm = -100 mV. D. Unblocked. E. Cytoplasmic 
solution contained 50 pM DPC. F. Cytoplasmic solution contained 50 pM 
FFA. Expanded traces at right are taken from the region indicated by the short 
bar above the unexpanded trace. Horizontal line indicates the closed level in 
both expanded and unexpanded traces. Asterisk in trace E denotes an example 
of a sojourn in the subconductance state. 
Figure 8. 
ll-54 
Summary of the effects of cytoplasmic drugs on CFTR kinetics, in 
representative experiments. V m = -100 m V. Upper panel: histograms of closed-
time durations within a burst. Value of 't shown is the average closed time 
calculated from fitting the histogram with one (-r1) or two (-r1 and 't2) 
exponential components. On each histogram, the maximum range of the 
ordinate is labeled. Lower panel: open-time duration histograms. Binwidth 
was 0.1 ms for closed-time histograms and 1 ms for open-time histograms. For 
cytoplasmically applied FFA, the ratio of areas under the curves for the short 
and long closed time constants indicates that the latter accounted for 49 ± 2% 
of the closed events (n = 4). 
II-55 
Figure 9. Effect of DPC and FFA at the external surface of excised, inside-
out patches. A-C. V m = + 100 m V. A. No added blockers. B. Pipette solution 
contained 50 pM DPC. C. Pipette solution contained 50 pM FFA. D-F. V m 
= -100 mV. D. No added blockers. E. Pipette solution contained 50 pM DPC. 
F. Pipette solution contained 50 pM FFA. Expanded traces at right are taken 
from the region indicated by the short bar above the unexpanded trace. 




Summary of the effects of external drugs on CFTR kinetics, in 
representative experiments. Vm = -100 mV. Axes and scales as in Figure 8. 
Upper panel: closed-time duration histograms. Lower panel: open-time duration 
histograms. For externally applied FFA, the ratio of areas under the curves for 
the short and long closed time constants indicates that the latter accounted for 
45 ± 11% of the closed events (n = 3). 
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Figure 11. Blockade of CFTR currents by DPC and FFA in cell-attached 
mode. Patch currents measured before, A, and after, B, application of 200 pM 
DPC to the bathing medium. Expanded traces at the right are taken from the 
area indicated by the short bar above the unexpanded trace. The horizontal 
line indicates the closed level for channels at both time scales. C and D show 
currents measured before and after, respectively, application of 50 pM FFA to 
the bath. A and Bare from the same patch, as are C and D. In each case, V m 
= -100 mV. Traces shown in Band D were obtained 1-2 min after application 
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The cystic fibrosis transmembrane conductance regulator (CFTR) is both 
a member of the ATP-binding cassette (ABC) superfamily and a Cl--selective 
ion channel. We investigated the permeation pathway of human CFTR with 
measurements on conduction and on open-channel blockade by 
diphenylamine-2-carboxylate (DPC). We used site-directed mutagenesis and 
oocyte expression to locate residues in transmembrane domains (TM) six and 
twelve that contact DPC, and that also control rectification and single-channel 
conductances. Thus TM-12 and the previously investigated TM-6 line the 
CFTR pore. In each TM domain, residues in contact with DPC are separated 
by two turns of an a-helix. The contributions of TM-6 and TM-12 to DPC 
block and Ct permeation, however, are not equivalent. The resulting 
structural model for the conduction pathway may guide future studies of 
permeation in other Cl- channels and in other ABC transporters. 
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Introduction 
The gene defective in cystic fibrosis encodes the cystic fibrosis 
transmembrane conductance regulator, or CFTR (Riordan et al., 1989). CFTR is 
expressed predominantly in epithelial tissue, such as the cells lining the 
pancreatic duct and sweat duct, airway epithelia, and intestinal brush-border 
epithelia (Riordan, 1993). When heterologously expressed in a variety of cells, 
CFTR forms a CI- channel activated by protein kinase A plus A TP (Rich et al., 
1990; Anderson et al., 1991c; Kartner et al., 1991); in vivo, CFTR is essential for 
fluid secretion and absorption across epithelia, in at least some cases operating 
in tandem with an amiloride-sensitive sodium conductance (Jiang et al., 1993). 
Loss of function of CFTR leads to blockage of airway, pancreatic, and other 
ducts by abnormally thick mucus secretions. The predicted amino acid 
sequence reveals that CFTR is a member of the ATP-binding cassette (ABC) 
superfamily, with a common motif consisting of twelve putative membrane 
spanning domains and two nucleotide binding folds; CFTR also has a unique 
regulatory (R) domain (Riordan et al., 1989; Figure 1). The channel is opened 
by phosphorylation by protein kinase A (PKA) of consensus sites in the R-
domain (Cheng et al., 1991) or cryptic sites (Chang et al., 1993), plus ATP 
binding (Quinton and Reddy, 1992) and hydrolysis (Anderson et al., 1991a; 
Baukrowitz et al., 1994) at the nucleotide binding folds. Unresolved issues 
include the mechanism by which phosphorylation plus ATP opens the channel, 
whether CFTR actively transports another substrate, how CFTR regulates an 
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additional, outwardly rectifying, epithelial CI- channel (Egan et al., 1992; 
Gabriel et al., 1993), and which domains of CFTR compose its pore region. We 
address the latter question here. 
In an earlier study (McCarty et al., 1993), we showed that: (1) CFTR 
heterologously expressed in Xenopus oocytes is blocked by diphenylamine-2-
carboxylic acid (DPC); (2) the block is voltage-dependent, with block occurring 
at hyperpolarizing, and not depolarizing, potentials; (3) Woodhull model 
analysis of the voltage dependence of blocker affinity indicates that the DPC 
binding site is ::::40% (8 = 0.41) of the electrical distance through the membrane 
field from the cytoplasmic side (Woodhull, 1973); (4) DPC can block the 
channel from either side of the membrane at hyperpolarizing voltages, and so 
may be permeant; and (5) DPC causes a rapid, flickery block of CFTR single 
channel openings. In the present study, we add data showing that (6) the 
flickery block displays a bimolecular forward rate and a unimolecular reverse 
rate; and (7) DPC binds more strongly at reduced cl- concentration. These 
data indicate that DPC binds within the permeation pathway of CFTR to 
produce brief interruptions in cl- current. 
Because DPC binds within the Cl- permeation pathway, residues in 
CFTR that alter DPC binding affinity when mutated may line the pore. Similar 
strategies were used to identify the M2 region of the nicotinic acetylcholine 
receptor (Leonard et al., 1988) and the H5 and 56 regions of potassium 
channels as lining the pore (MacKinnon and Miller, 1989; Yellen et al., 1991; 
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Lopez et al., 1994). We have measured both K0 , the binding affinity of DPC 
for the channel, and e, the electrical distance of the DPC binding site within 
the pore. We combined site-directed mutagenesis with both whole-cell and 
single-channel recordings to identify residues in transmembrane domains (TM) 
six and twelve that govern c1· permeation and the affinity of the channel for 
DPC. DPC binding is weakened by some mutations in TM-6 and strengthened 
by some mutations in TM-12; in addition, some mutations actually move the 
major binding site from TM-6 to TM-12. The geometry of the residues 
mutated and the DPC molecule show that TM-6 and TM-12 are both a-helical. 
Other residues in TM-6 have been implicated in c1· permeation (Anderson et 
al., 1991b; Sheppard et al., 1993; Tabcharani et al., 1993), but no function has 
previously been found for the putative transmembrane domains in the C-
terminal half of the CFTR sequence. Although TM-6 and TM-12 occupy 
homologous positions in the CFTR molecule, their contributions to DPC 
binding and c1· permeation are asymmetric. This structural asymmetry 
between the two domains is consistent with known permeation and substrate 
transport properties of other members of the ABC superfamily. These results 
may guide future structure-function studies on other cl- channels. 
Results 
DPC binds in the c1· permeation pathway 
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The voltage dependence of DPC block shows that it binds within the electric 
field of the membrane, presumably within the pore formed by CFTR (Figure 2 
and Figure 3A). If DPC is an open-channel blocker of CFTR, interactions with 
c1· during the permeation process are expected. A change in DPC binding 
affinity under conditions of reduced extracellular Cl" concentration, then, 
would indicate that DPC binding depends not only on voltage, but on the 
amount of c1· within the pore, as though DPC and c1· compete for a common 
binding site. Indeed, the K0 for DPC block of wild-type CFTR at V m = -100 
m V decreased, from K0 = 276 pM in 100 mM bath c1· to K0 = 181 pM in 10 
mM bath c1· (compare Figure 3A and Figure 3B; Table 1). The reversal 
potential was -8 ± 1 m V with 100 mM Cl- (n = 15), and +48 ± 2 m V with 10 
mM c1· (n = 5), a shift near the value of +58 mV expected for a purely 
chloride-selective channel. Voltage-dependence of block was slightly 
weakened by lowered c1· (Table 1). Similar concentration effects occur for 
knockoff of tetraethylammonium (TEA), Ba2+, and charybdotoxin from K+ 
channel pores (Armstrong, 1971; Neyton and Miller, 1988; MacKinnon and 
Miller, 1988, respectively). The estimated CFTR pore diameter is 5.5 A 
(Tabcharani, J. A. and Hanrahan, J. W., 1993, Biophysical Journal 64, A17 
Abstract). DPC measures approximately 3 A at its narrowest and 9 A along its 
longest axis in vacuum (see Figure 9a), and the unhydrated c1· ion diameter is 
3.6 A (Hille, 1992). These dimensions are consistent with DPC being itself 
permeant, yet also preventing simultaneous c1· permeation. We reason that 
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residues of CFTR directly involved in DPC binding lie within the pore region. 
Serine 341 in TM-6 accounts for most of the DPC binding energy and 
governs conductance 
Analysis of the electrophysiological properties of site-directed mutants shows 
that serine 341 in TM-6 (Figure 1) accounts for most of the binding energy 
between the channel and DPC. Figure 3C shows data for CFTR in which 5341 
is mutated to alanine (S341A); the affinity of DPC for the mutant channel is 
reduced by approximately five-fold compared to wild-type (K0 = 1251 pM). In 
Figure 4, the K0 for blockade is plotted as a function of voltage. Figure 4B 
shows that the voltage dependence of the weaker binding for S341A is 
changed only slightly from the wild-type. In the S341A mutation, CI-
permeation in the absence of blockers is also changed: the S341A whole-cell 
currents rectify inwardly (Figure 3C), opposite to wild-type currents. Single-
channel measurements (Figure 5) show that the conductance is reduced to ""' 1 
pS for this mutation, although the single-channel kinetics appear qualitatively 
unchanged. According to topological models like Figure 1, 5341 lies just under 
halfway across the membrane from the cytoplasmic side, a distance 
corresponding to the electrical location of the DPC binding site (8 = 0.41) 
predicted from measurements on the wild-type channel. We conclude that 
5341 in TM-6 is a pore-lining residue. 
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This importance of S341 is supported by data on S341 T, in which a 
hydroxyl group is conserved on the sidechain. The S341 T mutation gives a K0 
for DPC binding intermediate to S341A and the wild-type (Table 1) and a 
smaller degree of inward rectification than S341A (data not shown). We 
believe that DPC interacts with the -OH of S341, probably through hydrogen 
bonding of the carboxyl moiety, but that DPC has limited flexibility in its 
binding configuration with the wild-type channel, since S341 T does not fully 
restore the affinity for DPC to wild-type levels. 
The DPC binding site can be moved to TM-12 
S1141 in TM-12 has a predicted position analogous to S341 in TM-6 
(Figure 1), yet mutation S1141A had no appreciable effects on DPC binding or 
Cl- permeation (Table 1). S1141 can, however, form a binding site for DPC 
when the S341 binding site is removed (S341A) and when the methionine and 
threonine residues immediately adjacent to S1141 are changed to match the 
isoleucine and phenylalanine residues immediately adjacent to S341. That is, 
the triple mutant S341A-M1140I-T1142F binds DPC more tightly than S341A 
alone, with an affinity close to that of the wild-type channel (Figure 3D, Figure 
4). In this triple mutant, the DPC binding site has been removed in TM-6 and 
recreated in TM-12. This shows that TM-12 also lines the pore. 
Residues closer to the extracellular face also affect DPC binding and affect 
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conductance weakly 
Mutations in TM-12 and TM-6 at positions closer to the extracellular 
membrane face also affected DPC binding, further implicating TM-6 and TM-
12 in pore formation. If 5341 interacts with the carboxyl group of DPC and the 
transmembrane domains are a-helices, then K335 in TM-6 and T1134 in TM-12 
(Figure 1) are predicted to lie adjacent to a phenyl ring of DPC (Figure 9b ). 
We therefore mutated T1134 and K335 to phenylalanine in order to increase 
hydrophobicity at these positions. In TM-6, K335F displayed no change in 
rectification or e, but slightly weakened DPC binding (Table 1). In contrast, 
K335E displayed slight inward rectification of unblocked currents, but this 
mutant had the same DPC affinity as wild-type CFTR (Figure 3F). In TM-12, 
the T1134F mutation increased DPC affinity to 74 ± 3 J1M, but did not change 
e (Figure 3E, Figure 4), suggesting that this mutation stabilizes DPC binding at 
its main site, 5341. Hence, residues 335 and 1134 also line the pore of CFTR. 
The increased binding of DPC on the T1134F mutant was confirmed at the 
single-channel level, as described below. 
T1134F single channels recorded in excised, inside-out patches had a 
smaller amplitude than wild-type, with conductance y = 5.8 ± 0.2 p5 (range 4.1 
to 6.4 p5, n = 14), versus y = 8.0 ± 0.4 p5 for wild-type (McCarty et al., 1993). 
This provides further evidence that T1134 lines the pore. As with 5341A, 
however, the Tl134F mutant channel kinetics are qualitatively similar to wild-
type, with seconds-long openings, uninterrupted at positive voltages and 
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interrupted by brief closures at negative voltages (Figure 6, Figure 7). Also 
like the wild-type, T1134F occasionally shows a long-lived subconductance 
state, with amplitude "" 60% of the full conductance. As noted previously for 
the wild-type channel (McCarty et al., 1993), the subconductance state in 
T1134F is not blocked by DPC (Figure 6B), as though DPC cannot reach its 
binding site at 5341 when the channel is in this state. 
A further test for open-channel block 
Application of DPC to the cytoplasmic surface of excised inside-out 
patches resulted in blocker-induced closures of three- to four-fold longer 
duration for T1134F than for wild-type, as expected from the increased DPC 
affinity of the T1134F mutation (Figure 6). The longer residence time of DPC 
on the T1134F channel enabled us to resolve the kinetics of blockade at several 
DPC concentrations with V m = -100 m V. Increasing the concentration of DPC 
at the cytoplasmic side of excised inside-out patches increased the number of 
brief flickery closed times, without changing their duration (Figure 7 A-E). 
The closed times of T1134F due to DPC lengthened to 1.8 ± 0.1 ms (averaged 
from 20, 50, and 100 pM) and were independent of DPC concentration (Table 
2, Figure 7, Figure 8). The channel open time decreased with increasing DPC, 
such that 1 I 't0 increased linearly with DPC concentration. Both effects agree 
with expectations for an open-channel blocker. In such a scheme, the channel 
is blocked when DPC binds and unblocked when DPC dissociates: 
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kon[DPC] 
CFTR +=± CFTR+DPC (blocked) 
koff 
where kon is the bimolecular rate constant for DPC binding to CFTR, and koff is 
the unimolecular rate constant for dissociation of the complex. The parameter 
koff is 1/'tc,DPC ( = 1/'tc2), while kon is the slope of the line of 1/ 't0 vs. DPC 
concentration. From Figure 8, the kon = 6.4 x106 M-1sec-1, and koff is 560 sec-1. 
In an important test of this scheme, we use the kinetic data to predict the 
equilibrium dissociation constant K0 = k0 ff/ kon = 88 p.M. This calculation 
agrees very well with the independently measured value of 74 pM obtained in 
the whole-cell measurements of DPC blockade at Vm = -100 mV. 
Note that the unblocked closed times of the T1134F channel, unlike the 
wild-type, are fit by two time constants; these time constants are nearly equal 
to those measured during DPC blockade. The higher the concentration of 
DPC, the more time spent in the long closed states (Table 2). 
Other mutations do not affect DPC binding 
Several serine or threonine to alanine mutations did not affect DPC 
binding (Table 1); this is further evidence for the specificity of the residues 
noted. For most mutants, DPC block was apparent at negative potentials only; 
exceptions are the blockade of outward currents for T1134F, due to the greatly 
increased affinity for DPC, and the triple mutation, due to the changed voltage 
dependence of block. All mutants showed time-independent currents, as did 
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the wild-type. Wild-type CFTR single channels in symmetrical Ct have a 
linear I-V relation; however, these whole-cell experiments show outward 
rectification for WT CFTR at strongly hyperpolarizing potentials due to the 
lower value of cytoplasmic [CI-] relative to that in the bath (McCarty et al., 
1993; see also Overholt et al., 1993). 
Discussion 
CFTR is an intriguing molecule, because (1) its topology resembles that of 
A TP-binding cassette (ABC) transporters, such as the multidrug resistance P-
glycoprotein (MDR), the antigen peptide transporters of the major 
histocompatibility locus, TAP-1 and TAP-2, and bacterial permeases, and yet 
(2) CFTR is a Ct channel, with no other known transported substrate. In 
addition, cloned chloride-selective ion channels have no common structural 
motif, such as the tetrameric domain arrangement found in voltage-gated 
cation channels, or the P-region apparently shared by all K+ channels. 
Characterization of the residues of CFTR involved in creating the pore, then, 
is relevant both to the study of cl- channels and to the study of the ABC 
superfamily. 
DPC is an open-channel blocker 
Results presented earlier (McCarty et al., 1993) and extended here show that 
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DPC binds within the pore of CFTR. (1) The block is voltage-dependent; (2) 
The block is flickery at the single-channel level; (3) The DPC block is enhanced 
by reduced Cl- concentration; (4) Mutation of residues within predicted 
transmembrane domains strengthens or weakens the block. (5) For the T1134F 
mutation, which has kinetics favorable for detailed study, the rate constant for 
blocking (inverse of the open time constant) increases linearly with [DPC]; but 
the rate constant for unblocking is independent of [DPC]. These data agree 
with the classical kinetic model in which the blockade is governed by a 
bimolecular forward binding step and by a unimolecular dissociation step 
(Lester, 1992). It is possible that DPC could reach its binding site in the pore 
through the lipid phase (McCarty et al., 1993), as demonstrated for the block of 
sodium channels by some local anesthetics (Hille, 1977). However, the route 
by which DPC reaches its binding site does not change the conclusions about 
the nature of the binding site. 
Although many observations presented here are consistent with the 
simple view that DPC is an open-channel blocker at wild-type and mutant 
CFTR channels, a complication is added by the observations that unblocked 
T1134F displays an extra closed time constant compared to wild-type, and that 
this time constant is similar to the residence time of DPC. For the wild-type 
channel, however, DPC produces closed times much longer than the 
endogenous closures (McCarty et al., 1993). We believe that the unblocked 
T1134F channel only coincidentally has a time constant near that of the lifetime 
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of DPC on the T1134F channel. The extra endogenous time constant may be 
caused by the insertion of a bulky hydrophobic group into the permeation 
pathway. 
The pore of CFTR is lined by TM-6 and TM-12 
We conclude that TM-6 lines the pore because mutation S341A lowers the 
single channel conductance by a factor of 8, reverses the direction of 
rectification, and removes most binding of the open-channel blocker DPC. 
Also in TM-6, mutation K335F slightly reduces DPC block, and mutation 
K335E gives inward rectification (see also Tabcharani et al., 1993). In TM-12, 
mutation T1134F strongly increases DPC affinity, as confirmed by single-
channel measurements, and significantly lowers the single channel 
conductance. The sequence M11401-S1141-T1142F in TM-12 restores DPC 
binding to the S341A mutant; these effects show that TM-12 also lines the pore. 
The identification of TM-6 and TM-12 as pore-lining domains is consistent with 
and extends previous structure-function work on CFTR. 
Previous studies of CFTR have found that mutation of positively 
charged residues in TM-1 and TM-6 (including K335E) give small changes in 
ionic selectivity (Anderson et al., 1991b), and that naturally occurring 
mutations of positively charged residues just extracellular to TM-2, or within 
TM-6 (R347P and R334W) reduce single-channel conductance and alter kinetics 
(Sheppard et al., 1993). Removal of positive charge at position 347 reduces 
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multiple-ion occupancy of the pore and lowers single-channel conductance 
(Tabcharani et al., 1993). Taken together, our results and those of others point 
to TM-6 as a principal determinant of Cl- permeation. Indeed, a truncated 
CFTR construct, including only the first six TM domains, the first nucleotide 
binding fold, and the R domain, is sufficient to form CFTR-like channels 
(Sheppard et al., 1994). The conduction pathway may include three ci-
binding sites on TM-6, controlled directly or indirectly by R334/K335, S341, 
and R347. The mutations R334W, R347P, and S341A may reduce single-
channel conductance by removing a cl- binding site. The mutant pore, with 
only two ion binding sites, would have less mutual repulsion between the CI-
ions, and, therefore, a lower conductance than the wild-type. 
Our study is the first to show an effect on conductance of any putative 
TM domain other than TM-6 and the first to show any effect on conduction for 
residues in the C-terminal half of the CFTR sequence. Nonetheless, our TM-12 
mutations have no or much weaker effects on permeation than corresponding 
mutations in TM-6. We conclude that TM-6 and TM-12 make asymmetric 
contributions to the pore. In earlier studies on the M2 region of nicotinic 
acetylcholine receptors, analogous mutations in different transmembrane 
helices at the same presumptive level in the channel had equivalent effects 
when performed separately and additive effects when performed 
simultaneously. It was concluded that the ACh receptor pore contains annuli 
whose properties are averaged from those of the individual side chains 
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(Leonard et al., 1988; Imoto et al. , 1988; Charnet et al., 1990). The asymmetric 
CFTR channel is apparently not such a featureless annulus. 
Role of hydroxylated side chains 
Results presented here are the first to implicate serine and threonine 
residues in c1· conduction at CFTR, and they evoke the well-known roles of 
these hydroxylated residues in the GABAA and glycine receptor c1· channels 
(Lester, 1992). Indeed, the transmembrane domains of CFTR localized to the 
pore here are homologous to the amphipathic M2 domains of the GABAA and 
glycine receptor Cl" channels (Figure 10). The abundance of polar serine and 
threonine residues in the sequences shown implies that sites in the CFTR pore 
might bind c1· by replacing the waters of hydration, a mechanism long 
proposed for selectivity (Eisenman and Horn, 1983) but recently challenged for 
K+ channels (Heginbotham and MacKinnon, 1992; Kumpf and Dougherty, 
1993). 
Allosteric effects of the mutations? 
It remains a formal possibility that the effects of site-directed mutations of 
CFTR on DPC block are due to propagated allosteric effects, rather than to 
direct changes in side-chain interaction with DPC. This possibility seems 
unlikely because of several findings. The mutation that produces the largest 
effect on DPC block, S341A, also lowers the single-channel conductance from 8 
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pS to 1 pS and changes the rectification from outward to inward. Only the 
most tortuous of arguments would conclude that mutation of a residue 
actually located outside the pore propagates allosterically to give all three 
effects. Furthermore, S341lies -40% through the proposed TM sequence, the 
electrical distance of the DPC binding site predicted by whole-cell 
measurements on wild-type CFTR (McCarty et al., 1993), in support of the 
direct physical identity between the mutated residues and the DPC binding 
site. The possibility that the effects of S341A are allosteric is also rendered less 
likely by the intermediate effect on both drug block and rectification of 
replacing S341 with another hydroxylated residue, threonine. The presumed 
scenario of a non-specific effect of S-to-A being propagated extensively while 
the same non-specific effect of S-to-T also propagates, but to a lesser degree, 
seems unlikely. The conservative S341T mutation alone weakens DPC block 
enough to implicate residue S341 in binding DPC. In addition, other 
mutations of hydroxylated residues in TM-6, namely T338A and T339A, affect 
neither DPC block nor rectification (Table 1). This argues against the proposal 
that any alteration in sequence within TM-6 causes non-specific effects, and is 
further evidence for the specificity of the S341A mutation. Similarly, in TM-12, 
mutation T1134F strengthens DPC binding and also reduces single-channel 
conductance from 8 pS to <6 pS. DPC binds at the same electrical position, 
40% of the way through the membrane, in the T1134F mutant as in the wild-
type, evidence that T1134F makes no gross mutations in the binding site. 
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Control mutation T1134A has insignificant effects on DPC binding, as does 
mutation S1118A, in TM-11 at a position homologous to T1134. In the absence 
of atomic-scale structural data on CFTR, the simplest interpretation of our data 
is that the effects of the mutants are due to differences in direct side-chain 
interactions with DPC and the c1· permeation pathway. 
A proposed a-helical model of the pore 
The data presented support a model (Figure 9B,C) in which the pore of the 
CFTR channel is made up of TM-6 and TM-12, with contributions from other, 
as yet unidentified transmembrane domains. In addition, multiple contacts 
made by DPC within the pore indicate that both TM-6 and TM-12 line the pore 
and are a-helical. The data show that positions 1134 and 1141 both interact 
with DPC. If the 8-residue span of TM-12 including these residues is a-helical, 
positions 1141 and 1134 are two turns of the helix (10.8 A) from each other and 
on the same side. They would then interact with moieties separated by the 
longest axis of the DPC molecule (9 A), presumably the carboxyl group and the 
distal phenyl ring. An extended structure, for instance, a ~ strand, would 
place positions 1134 and 1141 too far apart to interact simultaneously with a 
DPC molecule. Mutations at positions 335 and 341 also independently weaken 
DPC binding without changing the binding site; hence, we conclude that the 
intervening span of TM-6 also has an a-helical structure. 
The relative orientation of the side chains on the phenylalanines of 
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K335F and T1134F may explain the opposite results of phenylalanines placed 
at these nearly equivalent positions. In our model of TM-12, the phenyl ring 
of T1134F points directly into the pore and lies along and perpendicular to the 
second phenyl ring of DPC. This proximity may stabilize DPC binding by 
bringing the 1t electron cloud of one phenyl group next to the positive charge 
of the plane of carbon atoms of another group. In TM-6, the K335F mutation 
slightly decreased DPC binding affinity; Figure 9C shows how a phenyl ring at 
position 335 would lie parallel to and farther away from the second phenyl 
ring of DPC, destabilizing DPC binding at S341. 
The interaction between cr- and DPC 
How would lowered external Cl- affect the voltage dependence of DPC 
block? If external chloride occupies a binding site at the DPC binding site or 
nearby, it could destabilize DPC binding by steric and/ or electrostatic effects. 
Lowering of external Cl-, resulting in reduced occupancy of the external Cl-
site, would stabilize DPC binding. An analogy is found for Ba2+ block of Ca2+-
activated K+ channels, where the Ba2+ off-rate is raised and the voltage 
dependence of internal Ba2+ block is changed, even to reversal, by raising 
external K+ (Neyton and Miller, 1988). Our data suggest that an interaction 
between DPC and cl- occurs at or near S341, for mutations here affect both 
DPC block and Ct binding. The triple mutation could reduce 8 by similarly 
affecting local concentrations of Cl- within the pore. Residues whose 
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mutations change 8, like S341, would be sites of competition between Cl- and 
DPC. Mutations affecting DPC affinity alone, with no effect one, like K335 or 
T1134, would be interacting with DPC directly without influencing competition 
with CL 
Implications for substrate specificity in ABC transporters 
Our results also shed light on functional aspects of ABC transporters. The 
MDR is the closest known homolog to CFTR. MDR mediates the efflux of 
amphiphilic cytotoxic drugs in an ATP-dependent manner (Germann et al., 
1993), but some experiments suggest that it may also be a volume-regulated Cl-
channel (Valverde et al., 1992). Photoaffinity labeling of MDR has shown that 
regions close to or in TM-6 and TM-12 contain drug binding sites 
(Greenberger, 1993). This suggests that the permeation pathway localized here 
for CFTR may occur in MDR as well. MDR has a rather broad substrate 
specificity, perhaps because the permeant substrate makes most of its contacts 
with only one helix, as found here for Ct through CFTR. It will be of interest 
to determine whether the individual residues governing cl- and drug 
permeation through MDR have positions analogous to those reported here. 
Other ABC transporters, such as STE6 in yeast and the mammalian 
endoplasmic reticulum peptide transporters, have considerably higher 
substrate specificity than does MDR (Germann et al., 1993). We suggest that 
such specificity can arise if several helices make simultaneous asymmetric 
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contact with the permeant substrate. It is not known whether TM-6 and TM-
12, two helices that line the CFTR permeation pathway, also subserve 
permeation in other ABC transporters. Such similarity of structure and 
function would further bridge the narrowing conceptual gap between 




The full coding region of CFTR in pSP64 (McCarty et al., 1993) was 
excised by digestion with Pst I and Sac I and transferred into the 
corresponding Pst I and Sac I sites of pAlter (Promega), which contains a 
deficient ampicillin resistance gene. Site-directed mutants were made by 
annealing an ampicillin repair oligonucleotide and an oligo containing the 
mutagenic sequence to single-stranded pAlter-CFTR, filling in and ligating 
with T4 polymerase and ligase, and transforming into BMH 71-18 mutS 
(Clontech) mismatch repair-deficient cells under ampicillin selection. The 
resulting plasmids, a mixture of pAlter-CFTR plasmids which did and which 
did not receive both oligos, were transformed into TOP 10 F' cells. Mutant 
CFTR colonies were selected for incorporation of a silent restriction site 
engineered into the mutagenic oligo. All mutants were sequenced in both 
directions around the mutation. Capped transcripts (2-35 ng) were coinjected 
with 0.1-0.5 ng of ~2-adrenergic receptor cRNA into Xenopus oocytes as 
previously described (McCarty et al., 1993). 
Electrophysiology 
Two-electrode voltage clamp data were acquired at room temperature 
(20 °C) with a GeneClamp 500 and pCLAMP software (Axon Instruments). 
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The corner frequency was 2kHz. Recording medium contained (mM): 96 
NaCl, 2 KCl, 1 MgC12, 5 HEPES, pH 7.4 to 7.5. For low Ct experiments, the 
recording medium was the same, with a substitution of 90 mM Na-isethionate 
for 90 mM NaCl. Recording electrodes (resistance 1-2 MQ) were filled with 3M 
KCl. The chamber was connected to ground via two Ag-AgCl pellets 
connected to the virtual ground bath clamp headstage. Background currents 
with and without DPC were subtracted from the blocked and unblocked 
currents shown in the figures. CFTR currents were activated by bath 
application of 1 pM isoproterenol; activation was maintained at a constant 
level by reapplication of isoproterenol as needed. For I-V curves, current was 
averaged over 50 ms from the latter part of each voltage step. For whole cell 
trials, K0 was calculated from K0 = I*(200pM) I (10 - I) for each cell; I, the 
current with DPC, and I0, the current in the absence of DPC, were determined 
empirically at V m = -100 m V. K0 and 8 calculations assume a valence of unity 
and a single binding site for DPC. 
Single channel currents were recorded from manually stripped oocytes 
injected with 70 ng T1134F cRNA or with 100 ng S341A plus 0.8 ng ~2-AR 
cRNA; when necessary, channels were activated in cell-attached mode with 
5pM forskolin, 100pM IBMX, 100 pM dibutyryl-cAMP and/ or 1 pM 
isoproterenol. Patch pipette solution contained (mM): 150 N-methyl-D-
glucamine-Cl, 0.5 MgC12, and 10 TES, pH adjusted to 7.4 with Tris. The 
intracellular solution for inside-out patches contained (mM): 150 NMDG-Cl, 1.1 
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MgC12, 2 Tris-EGTA, 10 TES, and 1 Mg-ATP (from equine muscle, < 1 ppm 
vanadium), pH 7.4. For the record of wild-type CFTR in Figure 6C, the 
cytoplasmic solution also contained 10 mM NaP, which did not change the 
unblocked open- or closed-times (McCarty et al., 1993). When filled with the 
pipette solution, patch pipette resistances were ""20 MO. Seal resistances 
ranged from 30 to >300 GO. Records were taken with the GeneClamp 500 at 2 
kHz and stored on videotape. During acquisition by the Fetchex program of 
pCLAMP 5.5, currents were filtered at 1 kHz with an 8-pole Bessel filter 
(Frequency Devices, Inc.), and digitized at 10kHz. T1134F single-channel 
traces were amplified at 20 dB/ decade during acquisition. For the S341A 
mutation, which results in single channels of very low conductance, currents 
were filtered at 100Hz and amplified at 20 dB/ decade during acquisition. 
Events lists were generated by Fetchan version 6.0 and analyzed with pStat 6.0; 
the simplex maximum-likelihood algorithm was used to fit exponentials to 
open- and closed-time duration histograms. System dead time was 0.3-0.4 ms. 
The first bin (from 0 to 1 ms) was excluded from open-time fits, and closed-
time fitting began at 0.5 ms. Inward currents (anions passing from the 
cytoplasmic solution to the external, pipette solution) are shown as downward 
deflections from the baseline. Statistics are mean± S.E.M. All other methods 
and reagents are as previously described (McCarty et al., 1993). 
Molecular Modeling 
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Calculation of DPC structure and display of the models was performed 
with HyperChem 2.0 (Autodesk, Inc.) running under Windows 3.1. Vacuum 
structure of DPC was obtained using MM+ energy minimization. 
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TABLE 1 Affinity and voltage-dependence for block of CFTR variants by DPC 
TM Kn(-too) 1-V Relation 
Construct ## (J.LM) e n Properties 
Wildtype 276 ± 14 0.41 ± 0.01 15 Linear; Erev = -8 ± 1 rn V 
WT Low [Cno (10 mM) 181 ± 13* 0.32 ± 0.02* 5 Erev = +48 ± 2 m V 
K335E 6 303 ± 14 0.42 ± 0.01 5 Inward Rectification 
K335F 6 351 ± 15* 0.42 ± 0.02 4 Linear 
T338A 6 220 ± 14 0.36 ± 0.02* 7 Linear 
T339A 6 284 ±47 0.44 ± 0.12 3 Linear 
S341A 6 1251± 116* 0.49 ± 0.03* 8 Strong inward rectification 
S341T 6 530 ± 80* 0.35 ± 0.09 3 Inward rectification 
Slll8A 11 243 ± 37 0.40 ± 0.02 5 Linear 
Tll34A 12 230 ± 20 0.35 ± 0.02* 6 Linear 
Tll34F 12 74±3* 0.41 ± 0.01 5 Linear 
Sl141A 12 220 ± 13 0.42 ± 0.03 5 Linear 
Triple 6,12 325 ± 26t 0.2l± O.Ol*t 7 Strong inward rectification 
Affinity for DPC was determined empirically at -100 mV, from whole-cell currents measured in the presence of 
200 IJ.M DPC, using the same experimental protocol as in Figure 2. e is expressed as the fractional electrical 
distance from the intracellular end of the pore. For these experiments, the slope was calculated from the Ko(V) 
values over the range of -140 to -60 m V. That e approximated the WT value of 0.41 for the mutations in TM6 
and TM12 provides evidence that these mutations made no gross perturbation in overall channel structure. 
Properties of the 1-V relation were determined from the average current levels over the fmal 50 ms of a 75 ms 
voltage step for WT and all mutants. Erev is the reversal potential, determined empirically from the voltage steps. 
Triple refers to the S341A-Ml1401-Tl l42F mutant. 
TM## Transmembrane domain. 
Values given are mean± S.E.M. for n oocytes. 
*,t p < 0.025 by unpaired t-test compared to WT or mutant S341A, respectively. 
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TABLE 2 Time constants for block of T1134F single channels by various 
DPC concentrations 
[DPC] n Area, 'tcz 
0 8.4 ± 0.7 0.31 ± 0.02 1.9 ± 0.14 4 0.13 ± 0.01 
20 4.6 ± 0.4 0.31 ± 0.05 1.9 ± 0.13 3 0.28 ± 0.05 
50 3.2 ± 0.3 0.39 ± 0.03 2.0 ± 0.33 3 0.47 ± 0.07 
100 1.3 ± 0.1 0.46 ± 0.02 1.6 ± 0.13 3 0.61 ± 0.07 
Time constants are in ms; [DPC] is in ~- Given time constants are averaged from n closed-
and open-time histograms such as in Figure 6 and Figure 7. Open-time histograms were fit 
with a single exponential; closed-time histograms were fit with two. All records taken at V m 
= -100 mV from inside-out patches excised into 1 mM ATP plus the given concentration of 
DPC. [DPC]: the concentration of DPC. 1:
0
: the open time constant. 'tc1: the first closed time 
constant. 1:c2: the second closed time constant. Area, 'tc2 : the percent of the total closed time 
due to the second closed time constant. Values given are mean± S.E.M. for n patches. 
Figure 1. Predicted transmembrane topology of CFTR with location of 
selected mutation sites. 
III-36 
1, K335. 2, 5341. 3, T1134. 4, 51141. NBFl & NBF2, nucleotide binding 
folds 1 and 2. R, R-domain. 
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Figure 2. Macroscopic waveforms for DPC blockade of wildtype CFTR. 
Voltage was stepped to test potentials between -140 and +80 mV at 
increments of +20 mV from a holding potential of -45 mV. CFTR currents 
were isolated by subtraction of background currents (see Methods). (a) Wild-
type CFTR currents. (b) Same cell with 200 ].1M DPC in the bath. The current 
traces for -140 mV and -80 mV overlap, as do the currents at -120 mV and -100 
mV. 
Figure 3. 1-V relations of representative cells for wild-type CFTR and 
selected mutants, with and without blockers. 
III-38 
Points for 1-V traces are averaged over 50 ms from the latter half of each 
voltage step, using the voltage protocol in Figure 2. Hollow circles, unblocked 
CFTR currents. Filled circles, currents with 200 pM DPC. (a) Wild-type CFTR 
current. (b) Data from another cell. Wild-type current in low external CI-
solution, showing increased block at hyperpolarized potentials and shifted 
reversal potential. (c) S341A mutant, showing strong inward rectification and 
decreased DPC block. (d) Triple mutation (S341A-M11401-T1142F), showing 
strong inward rectification and restored DPC block compared to (c) . (e) 
Tl134F mutation, showing increased block at all voltages. (f) K335E mutation, 
indicating inward rectification and unchanged DPC binding affinity. 
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Figure 4. Voltage dependence of blocker affinity for wild-type and three 
mutations of CFTR. 
Hollow circles, wild-type. Filled circles, T1134F. Hollow boxes, S341A. 
Filled boxes, triple mutation (S341A-M11401-T1142F). Points are an average 
from n separate cells (n for each type is given in Table 1). S.E.M. are shown 
where they exceed the size of the symbols. (A) Fraction of CFTR current 
remaining after bath application of 200 J.1M DPC. I0, current before DPC 
application. I, current with DPC. Data from individual cells were taken 
directly from background-subtracted records for each voltage. (B) K0 
calculated from K0 = I*(200 J.1M) I (10 - I) plotted on a semilogarithmic scale. 
Line shown is the regression line. Slope is proportional to the electrical 
binding distance, e. Values for these and other mutants are summarized in 
Table 1. 
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Figure 5. S341A has a low single-channel conductance. 
Currents are from channels in cell-attached mode. Data are filtered at 
100 H z to resolve the openings clearly. The horizontal line indicates the closed 
level. (a) Vm = +100 mV. (b) Vm = -100 mV. 
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Figure 6. The residence time of DPC on the T1134F channel is longer than 
on the wild-type channel. 
Single-channel records are from inside-out patches excised in 1 mM ATP 
with V m = -100 m V, filtered at 1 kHz. Expanded traces at right are taken from 
the region indicated by the short bar above the unexpanded trace. The 
horizontal line represents the closed level. (a) Wild-type CFTR, with 200 pM 
DPC added to the cytoplasmic side of the patch. Open-channel block by DPC 
causes brief closures. (b) T1134F mutant, with 200 pM cytoplasmic DPC. Note 
the subconductance state, indicated by an asterisk, which does not show the 
short DPC-induced closed times. (c) Representative closed-time histogram for 
the unblocked Tl134F channel. (d) Representative closed-time histogram for 
Tl134F with 50 pM DPC added to the cytoplasmic side. Note the greater 
number of longer closed times with DPC present, as compared to (c). Mean 
values for time constants are given in Table 2. 
111-42 
Figure 7. Mean open time decreases with increasing DPC concentration. 
Single-channel traces are shown for T1134F mutants, from inside-out 
patches excised in 1 mM Mg-ATP plus DPC. A-E: 0, 20, 50, 100, and 200 pM 
DPC respectively. Patches are clamped at Vm = -100 mV. The horizontal line 
represents the closed level for each trace. Note that the frequency of brief 
closures increases with DPC concentration, while the closure duration is 
unchanged. For 0, 20, 50, and 100 pM DPC, at right are open-time histograms 
from representative patches, fit with single exponentials. Note that the mean 
open time decreases with increasing [DPC]. The bin from 0 to 1 ms is not 
shown. The maximum values for the ordinates in each histogram are: for 0 
pM, 675 events detected; 20 pM, 2400; 50 pM, 2600; 100 p.M, 7500. Mean 
values for open- and closed-time constants are given in Table 2. Block by 200 
pM DPC produce flickers that were too rapid for quantitative analysis; 
however, the data show a qualitative trend toward further decreases in open 
time. 
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Figure 8. Further kinetic analysis of the data for DPC blockade of T1134F. 
Hollow circles, 1/'t, where 't represents open time. Filled circles, 1/'t, 
where 't represents the second (DPC-induced) closed-time constant within a 
burst. The horizontal line marks the average of 1/'tc2 for 20, 50, and 100 pM 
DPC. Note that 1/'t0 increases with [DPC], while 1/'tc2 is constant, as 
predicted by the bimolecular scheme given in the text. The DPC off-rate, koff, 
is given by koff = 1/'tc2 = 560 sec-1 . Also 1/'t0 increases with [DPC] at a rate kon 
= 6.4 x 106 M-1sec-1 . The equilibrium DPC dissociation constant K0 = kofflkon = 
88 J.1M at Vm = -100 mV. 
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Figure 9. Model of DPC binding within the pore of CFTR. 
(a) Structure of DPC in vacuum. (b) Model of DPC interactions with TM-6 
(left) and TM-12 (right). TM-6 and TM-12 are modeled as a-helices based on 
the interactions of DPC with the highlighted residues (see text). Highlighted 
residues in TM-6 are K335 and S341. Highlighted residues in TM-12 are T1134 
and S1141. DPC is shown between the two transmembrane domains; the 
carboxyl moiety is nearly parallel to and on the other side of the lower phenyl 
ring, adjacent to S341. External face of the membrane is towards the top of the 
picture. (c) Same as (b), with mutations K335F and T1134F highlighted. Note 
that K335F lies parallel to the second phenyl ring of DPC and T1134F lies 
perpendicular. We do not exclude the possibility that DPC might also bind in 
the reverse orientation, with phenyl rings extending towards the intracellular 
side from S341. We assume that transmembrane domains other than TM-6 
and TM-12 also contribute to the pore, and would lie in front of and behind 
the plane of the picture. Red, oxygen; light blue, carbon; dark blue, nitrogen; 
white, hydrogen; yellow, sulfur. 
Figure 10. Sequence alignment of CFTR TM-6 and TM-12 with the M2 
region of the rat glycine receptor alpha subunit. 
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Shading indicates similar residues; boxes highlight serine and threonine 
residues. Numbers label the first (left) and last (right) residues, from N to C 
terminal, in each transmembrane domain. TheN-terminal ends are 
extracellular for TM-6 and TM-12, intracellular for the glycine receptor M2 
(Grenningloh et al., 1987). 
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FFA on the T1134F mutant 
As described earlier, the T1134F mutation has an endogenous closed-
time constant approximately equal to the lifetime of DPC on the channel. This 
fact alone would imply that DPC acts not as an open-channel blocker, as 
suggested by evidence summarized in chapter 3, but to stabilize an 
endogenous closed state. On the wild-type channel, however, DPC lengthens 
the closed times well beyond the endogenous times. And 8, the DPC binding 
site, is identical for the wild-type and for the T1134F mutant. To be consistent 
with all the data, a stabilization mechanism suggests that the mechanism of 
DPC block is totally different for T1134F and the wild-type channels. 
Nevertheless, in a further effort to separate the endogenous time 
constant from the blocker-induced time constant, the effect of FFA on the 
T1134F channel was assayed. The lifetime of FFA on the wild-type channel is 
=double that of DPC. Thus, it was hoped that FFA would have a 
correspondingly higher affinity than DPC for the T1134F channel, and give a 
clear third time constant to the closed time distribution. This would further 
prove that the similarity between the endogenous second closed time constant 
and the DPC-induced closed time constant is coincidental. 
T1134F single-channels were excised into 1mM ATP, with 50 pM FFA in 
the pipette, and held at V m = -100 m V (see Figure 1; all methods exactly as in 
chapters 2 and 3). Unfortunately, FFA blocks T1134F more poorly than it 
blocks the wild-type channel (n = 3). The off-rate is slightly less than for the 
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wild-type channel ('1:02 = 1.6 ± 0.04 msec; WT '1:02 = 1.41 ± 0.12 msec), but the 
on-rate is significantly lower ('1:0 = 4.3 ± 0.2 msec; WT '1:0 = 2.4 ± 0.1 msec). The 
model of blocker binding in chapter 2, Figure 9, applied to FFA, would place 
the trifluoromethyl group of FFA next to T1134. It is not surprising, therefore, 
that FFA cannot access its binding site on the T1134F mutant as easily as on 
the wild-type channel. Although this result failed to separate the endogenous 
and the blocker-induced time constants of T1134F, it further implicates T1134 
as a pore-lining residue. 
Mutations in transmembrane domain 11 
It is extremely unlikely that only two TM domains, 6 and 12, form the 
pore of a monomeric CFTR. More likely, CFTR is a multimer, or else other 
transmembrane domains contribute to the monomeric pore. A multimeric 
pore could also involve TM domains other than 6 and 12. To address the 
possibility of additional pore-lining TM domains, the same strategy was used 
as for the "triple" mutation in TM-12 that restored DPC binding to the S341A 
mutant. In TM-12, the I-S-F sequence could bind DPC in the absence of S341. 
The same approach was taken with TM-S and TM-11: the mutations V922I-
A923S-D924F ("trip-S") and F1111-Il112S-A1113I ("trip-11") were subcloned into 
the pAlter-CFTRIS341A cassette using Nco-I and Hpa-I restriction enzymes. 
The resulting constructs are termed "trip-S I S341A" and "trip-11 I S341A." 







N-330 G I I L R K I F T T I S F C I V L R M A V350-C 
C-1123G T T L I !i I F T VA IF F I V F I M E I1103-N 
C-1123G T T L I S I F T V I S F F I V F I M E I1103-N 
N-912 S Y Y V F Y I Y V G VA D T L L A M G F F932-C 
N-912 S Y Y V F Y I Y V G I S F T L L A M G F F932-C 
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Trip-S/ S341A did not express, though RNA of the proper length was 
synthesized and injected (data not shown). Trip-11/ S341A did express; 
whole-cell currents showed the inward rectification characteristic of S341A 
(Figure 2). The DPC block, however, was intermediate to wild-type and 
S341A, giving an inconclusive result. At V m = -100 m V, KD = 5S3 ± 30 }1M, and 
6 = 0.26 ± 0.02 (n = 5; see chapter 3, Table 1 for comparison to wild-type, 
S341A, and S341T). Note that this KD is similar to that of S341T; this may 
indicate that in the trip-11/ S341A mutation, DPC can access a binding site in 
TM-11, but that the serine of the new binding site (presumably I1112S) is not 
perfectly situated to bind DPC. In addition to the inconclusive value for the 
KD, the low value for e implies that the voltage-dependence of DPC block has 
been weakened. In the absence of a strong change in affinity, this further 
complicates interpretation. Another mutation was constructed to test the 
involvement of TM-11. 
In TM-12, the T1134F mutation gave a significant increase in DPC 
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binding affinity, yet no change in the binding site 8. Therefore, an analogous 
mutation, S1118F, was constructed in TM-11. Intriguingly, the S1118F mutation 
gave voltage-dependent current relaxations, the only mutant constructed to do 
so (Figure 3). The S1118F mutation also changed the voltage-dependence of 
DPC block, while the overall affinity of S1118F for DPC was roughly 
unchanged from wild-type: KD (-100 mV) = 266 ± 13 pM, 8 = 0.27 ± 0.01. If 
TM-11 is a-helical, mutation S1118F would place three phenylalanine residues 
in close proximity to each other, at positions 1107, 1111, and 1118. To see if 
these three phenylalanines were responsible for the current relaxations, the 
double mutation S1118F-F1111S was constructed. Unfortunately, this mutation 
also displayed current relaxations of approximately the same time constants 
(Figure 3). Note that currents from the S1118A mutation (see Chapter 3, Table 
1) were time-independent. This suggests that it is the presence of 
phenylalanine, not absence of serine, that causes the relaxations. The basis for 
the current relaxations is still unclear. 
The site-directed mutations constructed in TM-8 and TM-11 did not give 
conclusive data about pore-lining domains in addition to TM-6 and TM-12. 
However, some effects were seen, and the S1118F mutation is the only CFTR 
mutation ever reported to display time-dependent currents. Further 
experiments might investigate the single-channel basis of the relaxations, or test 
the oligomerization state of CFTR by fusing the cytoplasmic N- and C- terminii 
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